Epitope,MHC_classes,Serotype,MHC_alleles,Species,Categories,Protein_refs,Ref_type,Journal_refs
AAAGFVFTA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05777,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
AAAGIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6956-6962
AAARNQDWL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P40967,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 188 277-286
AAERGPGQML,CLASS-1,HLA-B44,B*4403,HUMAN,BACTERIAL,not applicable,Uniprot,AMERICAN JOURNAL OF CRITICAL CARE MEDICINE 2002 166 843-848
AAFDRKSDAK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
AAFQSSMTK,CLASS-1,HLA-A11; HLA-A3,A*1101; A*0301,HUMAN,VIRAL,P12497,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AAGIGIIQI,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,Q9L6N1,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
AAGIGILTV,CLASS-1; CLASS-2,HLA-A2; HLA-A2; HLA-A2; HLA-DR4; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0211; A*0204; A*0201; DRB1*0408; A*0209; A*0206; A*0205; A*0202,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3882-3891; JOURNAL OF IMMUNOLOGY 1996 157 787-797; INTERNATIONAL JOURNAL OF CANCER 1999 82 669-677; JOURNAL OF IMMUNOLOGY 1995 154 2257-2265; IMMUNOGENETICS 1995 41 178-228; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396; CORNEA 2000 19 S2-S6
AALGFVFAA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05777,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
AALGFVFTA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05777,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
AANDPIFVVL,CLASS-1,HLA-Cw8,,HUMAN,CANCER,P40126,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1739-1748
AANYWLSKGMPKQKIIIG,CLASS-1,H-2d,,MOUSE,NEMATODE,P29030,Uniprot,VACCINE 2002 20 3685-3694
AAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
AAQERRVPR,CLASS-1,HLA-A31; HLA-A31; HLA-A31,,HUMAN,CANCER,O95987; P78358; O95146,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
AARAAVFLAL,CLASS-1,HLA-Cw16,,HUMAN,CANCER,Q13072,Uniprot,CORNEA 2000 19 S2-S6
AARAVFLAL,CLASS-1,HLA-Cw16; HLA-Cw16; HLA-Cw16,Cw*1601,HUMAN,CANCER,Q13072,Uniprot,IMMUNITY 1995 2 167-175; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108
AASNDGPTI,CLASS-1,HLA-Cw8,,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1739-1748
AAVDLSHFLKEK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
ACDPHSGHFV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P33552; P11802,Uniprot,SCIENCE 1995 269 5228 1281-1284; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
ACQGVGGPGHK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P24736,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
ADLMGYIPLV,CLASS-1; CLASS-2,H-2d; HLA-A2; HLA-DR2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,H-2Dd; DRB2*0201,MOUSE; HUMAN,VIRAL,P29846; P27954; P27959; P26664,Uniprot,NATIONAL MEDICINE 1996 2 1104-1108; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; CYTOMETRY 2000 41 271-278; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123
ADRGLLRDI,CLASS-1,HLA-B8,,HUMAN,VIRAL,P04666,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 303-308
AEEAAGIGIL,CLASS-1,HLA-B45; HLA-B45,B*4501,HUMAN,CANCER,Q16655,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1998 75 451-458; CORNEA 2000 19 S2-S6
AEEAAGIGILT,CLASS-1,HLA-B45; HLA-B45,B*4501,HUMAN,CANCER,Q16655,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1998 75 451-458; CORNEA 2000 19 S2-S6
AENLWVTVY,CLASS-1,HLA-B44,,HUMAN,VIRAL,P19549,Uniprot,NATIONAL MEDICINE 1997 3 205-211
AENLWVTVYY,CLASS-1,HLA-B44,,HUMAN,VIRAL,P19549,Uniprot,NATIONAL MEDICINE 1997 3 205-211
AEVTQHGSY,CLASS-1,HLA-B44,,HUMAN,VIRAL,P26660,Uniprot,JOURNAL OF GENERAL VIROLOGY 1996 77 1305-1309
AFDAAVSGKSVS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
AFHHVAREL,CLASS-1,HLA-A2; HLA-B52,A*0201; B*5201,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 4174-4186
AFLPWHRLF,CLASS-1,HLA-A24; HLA-A24; HLA-A24; HLA-A24,,HUMAN,CANCER; SELF PEPTIDE,P14679,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 1343-1348; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
AFLPWHRLFL,CLASS-1,HLA-A24; HLA-A24,,HUMAN,CANCER,P14679,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 1343-1348; INTERNATIONAL IMMUNOLOGY 1997 9 327-338
AGPGRAFVTI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P04578,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 641-649
AGPHNDMEI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 868-874
AHYLFRNL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 121-130
AHYNIVTFCCK,CLASS-1,HLA-B18; H-2d,B*1801; H-2Kd,HUMAN; MOUSE,VIRAL,P03129,Uniprot,VIRUS RESEARCH 1995 37 13-22
AIFASSMTK,CLASS-1,HLA-A3; HLA-A11,A*0301; A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQASMTK,CLASS-1,HLA-A3; HLA-A11,A*0301; A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQCSMTK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQRSMTR,CLASS-1,HLA-A3; HLA-A11,A*0301; A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSAMTK,CLASS-1,HLA-A11; HLA-A3,A*1101; A*0301,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSATK,CLASS-1,HLA-A3,A*0301,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSMAK,CLASS-1,HLA-A3,A*0301,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSMTA,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSMTK,CLASS-1,HLA-A11; HLA-A3; HLA-A3; HLA-A11; HLA-A11,A*1101; A*0301,HUMAN,VIRAL,P03369,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938; JOURNAL OF IMMUNOLOGY 1995 154 4536-4545; PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221; JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
AIFQSSMTR,CLASS-1,HLA-A11; HLA-A3,A*1101; A*0301,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSMTT,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIFQSSMTY,CLASS-1,HLA-A3; HLA-A11,A*0301; A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
AIIDPLIYA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
AIINFEKL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667
AIIRILQQL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P05954; P05926,Uniprot,JOURNAL OF VIROLOGY 2001 75 1301-1311; JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
AILGFVFTA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05777,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
AILGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,Q9UPH8,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
AILHTPGCV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
AILSKTGDPV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P31873,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
AIMDKKIIL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P21431,Uniprot,VIROLOGY 1999 259 135-140
AIMDKNIIL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03496,Uniprot,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
AIMKFHSM,CLASS-1,H2-b,H2-Kb,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
AINNYAQKL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1994 39 467-479
AIYKKSQHM,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P02340,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 186 695-704
ALAHGVRVL,CLASS-1; n/a,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; LIVER 1996 16 174-182
ALASTAPPV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
ALCRWGLLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
ALFGYPVYV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03409,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
ALGLGLLPV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P46089,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
ALGSTAPPV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
ALIWEDLRSLCLFSY,CLASS-1,HLA-B22,,HUMAN,VIRAL,P03383,Uniprot,JOURNAL OF VIROLOGY 1996 70 8468-8476
ALIWNMDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
ALLAVGATK,CLASS-1,HLA-A3; HLA-A3,,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 5027-5033; CORNEA 2000 19 S2-S6
ALMDKSLHV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
ALMPLYACI,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; VIRAL,Q16655; P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101; EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
ALNFPGSQK,CLASS-1,HLA-A11; HLA-A3,A*1101; A*0301,HUMAN,CANCER,P40967,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
ALNKMFCQL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
ALPHAILRL,CLASS-1,Saoe-G*04; Saoe-G*06,,TAMARIN,SELF PEPTIDE,P02571,Uniprot,IMMUNITY 1995 3 583-590
ALPIEYGPLV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
ALPYWNFAT,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
ALQNAASIA,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
ALQNAASIAGL,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
ALQPGTALL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,O43653,Uniprot,CANCER RESEARCH 2000 60 5522-5528
ALSPFPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
ALSPYPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,IMMUNITY 1996 4 565-571
ALVEFEDVL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P14866,Uniprot,CANCER RESEARCH 2001 61 2038-2046
ALVGLFVLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
ALWGFFGVL,CLASS-1,HLA-A2,,HUMAN,MISCELLANEOUS,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396
ALWGFFPVI,CLASS-1,HLA-A2,,HUMAN,MISCELLANEOUS,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396
ALWGFFPVL,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9NPA0,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY PAPERS IN PRESS 2001
AMAPRTLLL,CLASS-1b,Qa-1a; Qa-1b,,MOUSE,VIRAL,P31614,Uniprot,CELL 1994 79 649-658
AMFQDPQER,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03126,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
AMGIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1750-1758
AMKGLPIRY,CLASS-1,HLA-B62,,HUMAN,VIRAL,P27915,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2754-2760
AMLDLLHVA,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
AMLGTHTMEV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802; CELLULAR IMMUNOLOGY 2000 204 29-37; CORNEA 2000 19 S2-S6
AMQMLKE,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03349,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2697-2703
AMQMLKETI,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03349,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 8578-8583
ANDPIFVVL,CLASS-1,HLA-Cw8,,HUMAN,CANCER,P40126,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1739-1748
ANHRALDLVA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2895-2902
ANVPNCDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
ANYDFICV,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P10259,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 13991-13996
APAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
APCMGLIY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
APDTRPA,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
APDTRPAP,CLASS-1,H-2d,H-2Dd,MOUSE,CANCER,P15941,Uniprot,VACCINE 2000 18 2059-2071
APDTRPAPG,CLASS-1,H-2b; H-2d,H-2Kb; H-2Ld,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
APGSTAPPA,CLASS-1,H-2b,H-2Db,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
APQKAGGFL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P09411,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 273-281
APRKKGCWKC,CLASS-1,HLA-B7,,HUMAN,VIRAL,P24736,Uniprot,VACCINE 2001 19 4385-4395
APTAGAFFF,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,VIRAL,P26020; P19902,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 2777-2781; MOLECULAR IMMUNOLOGY 1997 34 273-281
APTKAKRRVV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P35961,Uniprot,VACCINE 2001 19 4385-4395
APYLGWLVF,CLASS-1,H-2d,H-2Ld,MOUSE,CANCER,P19473,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
AQHPNAELL,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 121-130
AQTGNKTRLAFAGLKYADVG,CLASS-1,H-2d; H2-d,H2-Dd,MOUSE,VIRAL; BACTERIAL,P02931,Uniprot,INFECTION AND IMMUNITY 2000 68 2535-2545
AQYASTTRISES,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
ARFFPYYV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
ARGPESRLL,CLASS-1,HLA-Cw6,,HUMAN,SELF PEPTIDE,P78358,Uniprot,PROC.NATL.ACAD.SCI. USA 2000 97 10917-10922
ARKAITALTERLYVGGPMHN,n/a; CLASS-1,HLA-A1/A30/B35,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
ARNLVPMVATVQGQN,CLASS-1,HLA-A2,,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
ARRGREILL,CLASS-1,HLA-B7/HLA-B8,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF VIRAL HEPATITIS 2002 9 18-28
ARRHRILDIYL,CLASS-1,Mamu-B*03,,RHESUS,VIRAL,P31818,Uniprot,NATURE MEDICINE 1999 5 1270-1276
ARYWAIRTR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03467,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
ASCIGLIY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
ASCKGLIY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
ASCMGLIY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P21429,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
ASCMGLLY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
ASGPGGGAPR,CLASS-1,HLA-A31; HLA-A31; HLA-A31; HLA-A31; HLA-A3,A*0301,HUMAN,CANCER; SELF PEPTIDE,P78358,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9; CORNEA 2000 19 S2-S6; JOURNAL OF IMMUNOLOGY 1998 161 3596-3606
ASKNKEKAL,CLASS-1,HLA-B8,,HUMAN,PARASITE,P16893,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1435-1445
ASLDSDPWV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
ASNDGPTLI,CLASS-1,HLA-Cw8,,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1739-1748
ASNENMDAM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,Q07531,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1991 21 2069-2075
ASNENMETM,CLASS-1,H-2b; H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03467; P26065; P18277,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1991 21 2069-2075; MOLECULAR IMMUNOLOGY 1996 33 1323-1333; JOURNAL OF IMMUNOLOGY 2001 167 4869-4877
ASNENMETMESSTL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P31609,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1987 165 1508-1523
ASPCNSTVL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,not applicable,Uniprot,IMMUNITY 1998 9 687-698
ASQFHAGSLLVFMAP,CLASS-1,H-2b,,MOUSE,VIRAL,P12296,Uniprot,JOURNAL OF GENERAL VIROLOGY 1994 75 2925-2936
ASQIYAGIK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03368,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
ATCINGVCWTVYHGA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,HEPATOLOGY 2003 37 577-589
ATGFNLDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
ATGNLPGCSFSIFL,CLASS-1,H-2d,,MOUSE,VIRAL,P27954,Uniprot,HEPATOLOGY 1997 25 470-477
ATIGTAMYK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03209,Uniprot,JOURNAL OF VIROLOGY 1998 72 8644-8649
ATQIPSYKK,CLASS-1,HLA-A11,,HUMAN,CANCER,P15309,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
ATSVLAGL,CLASS-1,HLA-B58,,HUMAN,PARASITE,P04926,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
AVDISHFLK,CLASS-1,HLA-A1,A*0101,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
AVDLSHFL,CLASS-1,HLA-B15; HLA-B62,B*1501,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF VIROLOGY 1994 68 7336-7343
AVDLSHFLK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
AVFDAKSDAK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
AVFDRKADAK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
AVFDRKSDAK,CLASS-1,HLA-A11; HLA-A2; HLA-A11; HLA-A11; HLA-A11; HLA-A11,A*1101; A*0201,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938; JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 1801-1813; JOURNAL OF IMMUNOLOGY 1997 159 4753-4761; HUMAN IMMUNOLOGY 2000 61 972-984; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
AVFDRKSVAK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03203,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 915-926
AVGIGIAVV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P21926,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
AVLLHEESM,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03203,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
AVLNKSNREVR,CLASS-1,HLA-B27,,HUMAN,SYNTHETIC,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 2750-2759
AVMINCDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
AVNHYFKTR,CLASS-1,HLA-A11,,HUMAN,VIRAL,P12933,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
AVRHFPRIW,CLASS-1,HLA-B57,B*5701,HUMAN,VIRAL,P05926,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
AVSMTSSVL,CLASS-1,H-2d,H-2Kd,MOUSE,CANCER,P15941,Uniprot,VACCINE 2000 18 2059-2071
AVYNFATC,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P09991,Uniprot,VIROLOGY 1997 234 62-73
AVYNFATCG,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09992,Uniprot,JOURNAL OF VIROLOGY 1992 66 6755-6762
AVYNFATCGI,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P09991,Uniprot,VIROLOGY 1997 234 62-73
AYAGLFTPL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
AYDFLYNYL,CLASS-1,HLA-A24,,HUMAN,SELF PEPTIDE,Q9UL01,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 2565-2574
AYERMCNIL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P16982,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1507-1515
AYGLDFYIL,CLASS-1,HLA-A24; HLA-A24; HLA-A24; HLA-A24,,HUMAN,CANCER,Q13084,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 5944-5950; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
AYIDFEMKI,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 1999 59 4056-4063
AYISSGSSTL,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P01783,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 179 195-202
AYPLHEQHG,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 1801-1813
AYRALALEL,CLASS-1,HLA-B27; HLA-B24,B*2402,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF NEUROLOGICAL SCIENCE 2001 188 61-65
AYSQQTRGL,CLASS-1,HLA-A24,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF HEPATOLOGY 2001 34 930-935
CAGHNMDHI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
CALPFTSAR,CLASS-1,HLA-A11,,HUMAN,VIRAL,O43504,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
CAPPGYALL,CLASS-1,,Mamu-A*01,RHUESUS,VIRAL,P05885,Uniprot,JOURNAL OF VIROLOGY 1999 73 8035-8039
CCLCLTVFL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03386,Uniprot,IMMUNOLOGY LETTERS 1998 62 33-38
CESDIEKKI,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P02893,Uniprot,INFECTION AND IMMUNITY 1995 63 1955-1959
CGSHLVEAL,CLASS-1,H-2b,H-2Kb,MOUSE,SELF PEPTIDE,P01324,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 175 545-552
CHGSAACA,CLASS-1,H-2b,,MOUSE,ALLERGEN,P49278,Uniprot,JOURNAL OF IMMUNOLOGY 2002 169 2430-2435
CINGVCWTTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P29846,Uniprot,HEPATOLOGY 2001 33 1533-1543
CINGVCWTV,CLASS-1; n/a,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26664; P29846,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 95 521-530; JOURNAL OF CLINICAL INVESTIGATION 1997 100 2376-2385; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; HUMAN IMMUNOLOGY 2002 63 710-718; CELLULAR IMMUNOLOGY 2000 203 111-123; JOURNAL OF IMMUNOLOGICAL METHODS 2004 287 91-99
C(I/V)NGVCWTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P29846,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
CKGVNEEYL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244
CKGVNKEY,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03070,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2016-2023
CKGVNKEYL,CLASS-1,H-2b; H-2b; H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,JOURNAL OF VIROLOGY 1990 64 1192-1200; JOURNAL OF VIROLOGY 1992 66 440-447; INTERNATIONAL IMMUNOLOGY 1998 10 463-472; SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1994 39 467-479
CKGVNKEYLMY,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,JOURNAL OF VIROLOGY 1992 66 440-447
CLAGLLTMV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 4246-4271
CLALSDLLV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
CLGGLLTMV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF VIROLOGY 1993 67 7428-7435; JOURNAL OF IMMUNOLOGY 2000 165 4246-4271; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
CLIRLKPTL,CLASS-1; n/a,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; LIVER 1996 16 174-182
CLLDILDTA,CLASS-1,HLA-A2,,HUMAN,CANCER,P01118,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396
CLLDILDTAGL,CLASS-1,HLA-A2,,HUMAN,CANCER,P01118,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396
CLSWNGPHL,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF GENERAL VIROLOGY 1996 77 315-325
CLTEYILWV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P21100,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2003 197 927-932
CLTSTVQLV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,ANTICANCER RESEARCH 1997 17 1A 45-53; JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2109-2117
CLYGLLTMV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 4246-4271
CLYGNVEKV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P14866,Uniprot,CANCER RESEARCH 2001 61 2038-2046
CMHLLLEAV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 2000 60 6448-6456
CMTWNQMNL,CLASS-1,HLA-A24; HLA-A2,A*2402; A*0201,HUMAN,CANCER,P50902; P19544,Uniprot,BLOOD 2000 95 286-293; IMMUNOGENETICS 2000 51 99-107
CPEEKQRHL,CLASS-1,HLA-B18,,HUMAN,VIRAL,P17386,Uniprot,IMMUNOLOGY 1991 72 3-9
CPTNQQVVLEGTNKTD,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P11199,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
CQDKILTHYENDSTD,CLASS-1,HLA-A1; HLA-A3; HLA-A2; HLA-A11; HLA-A2,A*0205,HUMAN,VIRAL,P03120,Uniprot,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 1995 209 2 541-546
CQKTRIRAYAYILTAHNPVLV,CLASS-1,H-2S,,MOUSE,RAT,Q63343,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 102 189-198
CRASGVFTTSFGNTLTCYLK,CLASS-1,HLA-A3/A33/B44/B58,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
CRPLTDFDQGW,CLASS-1,HLA-B53,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
CRVLCCYVL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P13202,Uniprot,JOURNAL OF VIROLOGY 1999 73 8179-8184
CSIYPGHITG,CLASS-1,Patr-A*0402; Patr-A*0402,,CHIMPANZEE,VIRAL,P26664; P27953,Uniprot,IMMUNITY 1999 10 439-449; IMMUNITY 2001 15 883-895
CSLWNGPHL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P22432,Uniprot,JOURNAL OF VIROLOGY 1995 69 8127-8131
CTELKLSDY,CLASS-1,HLA-A1,,HUMAN,VIRAL,P26077,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1994 269 32426-32434
CTNVSTVQC,CLASS-1,HLA-Cw8,,HUMAN,VIRAL,P05878,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
CTPIDINQM,CLASS-1,Mamu-A*01,,MONKEY,VIRAL,P05893,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 4996-5003
CTPYDINQM,CLASS-1,,Mamu-A*01,RHUESUS; MONKEY,VIRAL,P05893,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071; JOURNAL OF IMMUNOLOGY 2001 167 4996-5003
CTPYDYNQM,CLASS-1,Mamu-A*01,,MONKEY,VIRAL,P05893,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 4996-5003
CVNGVCWTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,PROC.NATL.ACAD.SCI. USA 1999 96 5692-5697
DAAARVTAIL,CLASS-1,Patr-B*1701,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 2001 15 883-895
DADKYAVTV,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P17451,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6855-6866
DAEKCDKTDEY,CLASS-1,HLA-A1,,HUMAN,SELF PEPTIDE,P14679,Uniprot,CORNEA 2000 19 S2-S6
DAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
DAPIYTNL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,METHODS 1997 12 117-123
DASREAKKQVEKALEEANSK,CLASS-1,H-2d,,MOUSE,BACTERIAL,P02977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1999 29 2414-2419
DAYFSVPL,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P03368,Uniprot,HUMAN IMMUNOLOGY 1999 60 177-186
DCKTILKAL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
DDVWTSGSDSDEELV,CLASS-1,HLA-B35,,HUMAN,VIRAL,P18139,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
DEGEGRVI,CLASS-1,HLA-Kk,,MOUSE,VIRAL,P05769,Uniprot,VIRAL IMMUNOLOGY 2001 14 135-149
DELDYENDIEKKICKMEKCSC,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P13814,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244
DEVEFLGHY,CLASS-1,HLA-B18,,HUMAN,VIRAL,Q04360,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617
DFKDCERRF,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,P50902http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2000 95 286-293
DFKGKVLI,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,P53999,Uniprot,IMMUNOGENETICS 1998 48 56-61
DFMIQGGDF,CLASS-1,HLA-A24; HLA-A24,A*2402,HUMAN,SELF PEPTIDE,P23284,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 4994-5004; JOURNAL OF IMMUNOTHERAPY 2002 25 439-444
DILDTAGLE,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
DLCGSVFLV,CLASS-1; n/a,HLA-A2,A*0201,HUMAN,VIRAL,P26664; P27954,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742; LIVER 1996 16 174-182
DLDEPEQFRL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P16893,Uniprot,PARASITE IMMUNOLOGY 2000 22 501-514
DLIAQPIRLL,CLASS-1,HLA-A2,,HUMAN,VIRAL,not applicable,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
DLLEEGNTL,CLASS-1,HLA-A2,,HUMAN,PARASITE,Q9U0N9,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
DLLSHAFFA,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
DLMGYIPL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,Q01403,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
DLMGYIPLV,CLASS-1; n/a,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P27954; P27959,Uniprot,JOURNAL OF VIROLOGY 1994 68 3334-3342; JOURNAL OF VIROLOGY 1995 69 2462-2470; JOURNAL OF HEPATOLOGY 1999 31 407-415; IMMUNOLOGY AND CELL BIOLOGY 2003 81 67-72; LIVER 1996 16 174-182; JOURNAL OF MEDICAL VIROLOGY 2002 66 472-480
DLMGYIPLVGAPLG,CLASS-1,H-2d,,MOUSE,VIRAL,P27959,Uniprot,HEPATOLOGY 1997 25 470-477
DLNLGNLNV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P27958,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
DLNTMLNTV,CLASS-1,HLA-B14; HLA-B14,,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 175 961-971; AIDS 1991 9 1049-1059
DPARYEFLW,CLASS-1,HLA-B53,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2928-2936
DPNPQEVVL,CLASS-1,HLA-B51; HLA-B35; HLA-B35; HLA-B51,B*5101; B*3501,HUMAN,VIRAL,P19551,Uniprot,AIDS 1996 10 1075-1083
DPRRRSRNL,CLASS-1,HLA-B7; HLA-B7,,HUMAN,VIRAL,P27959; P26664,Uniprot,JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; CELLULAR IMMUNOLOGY 2000 203 111-123
DPSGAYFAW,CLASS-1,HLA-B53,B*5301,HUMAN,SELF PEPTIDE,P25787,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 367-371
DPVIDRLYL,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,P06830,Uniprot,VIROLOGY 1994 200 281-283
DRFSVNLDVKHFSPEE,CLASS-1,H-2g,H-2Ag,MOUSE,SELF PEPTIDE,P23927,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 104 47-57
DRFYKTLRA,CLASS-1,HLA-B14,,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF VIROLOGY 1996 70 5799-5806
DRFYKTLRAE,CLASS-1,HLA-B14,,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3727-3734
DSCMGLIY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
DSELEIKRYKNR,CLASS-1,HLA-B18,,HUMAN,VIRAL,P03206,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
DSYVPSAEQI,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P06914,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
DTPLIPLTIF,CLASS-1,HLA-B51,,HUMAN,VIRAL,P12978,Uniprot,SEMIN.IMMUNOLOGY 1992 4 97-104
DTVLEEMNL,CLASS-1,HLA-B18; HLA-A68,A*6802,HUMAN,VIRAL,P12498,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1758-1765
DVKQLTEVV,CLASS-1,HLA-A68; HLA-B18,A*6802,HUMAN,VIRAL,P24740,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1758-1765
DVRLVHRDL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
DVVYALKRQGRTLYGFGG,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
DYCNVLNKEF,CLASS-1,HLA-A24,,HUMAN,VIRAL,P03209,Uniprot,JOURNAL OF VIROLOGY 1998 72 8644-8649
DYGILQINSR,CLASS-1,H2-k,H2-Ak,MOUSE,MISCELLANEOUS,P00698,Uniprot,GENE THERAPY 1999 6 1826-1834
DYLDGSVKV,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03070,Uniprot,VIROLOGY 1998 244 427-441
DYMIQGGDF,CLASS-1,HLA-A24,A*2402,HUMAN,SELF PEPTIDE,P23284,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 4994-5004
DYSARWNEIFG,CLASS-1,HLA-A24,,HUMAN,SELF PEPTIDE,Q9UL01,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 2565-2574
EAAAIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6956-6962
EAAGIGILAV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6956-6962
EAAGIGILTV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 347-352; EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587; JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF IMMUNOLOGY 1998 161 6956-6962; CORNEA 2000 19 S2-S6
EADPTGHSY,CLASS-1,HLA-A1; HLA-A1; HLA-B35; HLA-A2; HLA-A1; HLA-B35; HLA-A1; HLA-A1; HLA-A1,B*3503; A*0201; B*3501; A*0101,HUMAN,CANCER,P43355,Uniprot,TISSUE ANTIGENS 2000 56 77-81; SEMIN.IMMUNOLOGY 1993 5 81-94; JOURNAL OF IMMUNOLOGY 1995 154 3961-3968; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; TISSUE ANTIGENS 2001 57 103-109; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
EAFIQPITR,CLASS-1,HLA-A28,,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 6057-6066
EALDKYELENHDLKTKNEG,CLASS-1,H-2d,,MOUSE,BACTERIAL,P02977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1999 29 2414-2419
EAMGIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1750-1758
EAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
EAQNTTYL,CLASS-1,H-2b,H-2Db,MOUSE,HUMAN,P06731,Uniprot,CANCER RESEARCH 2002 62 5058-5064
EAYGLDFYIL,CLASS-1,HLA-A24,,HUMAN,CANCER,Q13084,Uniprot,INTERNATIONAL IMMUNOLOGY 1997 9 327-338
EDLRVLSFI,CLASS-1,HLA-B37,B*3701,HUMAN,VIRAL,P03466,Uniprot,CELL 1986 44 959-968
EDSYVPSAEQI,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P06914,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
EEASVTVVEGOVDYY,CLASS-1,HLA-A1; HLA-Bw37,,HUMAN,VIRAL,P03120,Uniprot,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 1995 209 2 541-546
EECSQHLPYI,CLASS-1,HLA-B44,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF VIRAL HEPATITIS 2002 9 18-28
EEGAIVGEI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P08278,Uniprot,VIROLOGY 1993 193 289-295
EEKLIVVAF,CLASS-1,HLA-B44,B*4403,HUMAN,CANCER,not applicable,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 7976-7980
EEKLIVVLF,CLASS-1,HLA-B44; HLA-B44; HLA-B44; HLA-B44,B*4402,HUMAN,CANCER,not applicable,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 7976-7980; TISSUE ANTIGENS 1999 53 111-121; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
EEKRGSLHVW,CLASS-1,HLA-B44; HLA-B44,B*4403,HUMAN,SELF PEPTIDE; MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1999 189 301-308; EURO.JOURNAL OF IMMUNOLOGY 2002 32 2748-2758
EENLLDFVRF,CLASS-1,HLA-B44; HLA-B44; HLA-B44,B*4402,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 176 169-176; HUMAN IMMUNOLOGY 2001 62 791-798
EENLLDFVRM,CLASS-1,HLA-B44; HLA-B44,B*4403; B*4405,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 3619-3625
EFFWDANDIY,CLASS-1,HLA-B12,,HUMAN,VIRAL,P18139,Uniprot,BLOOD 2001 98 1872-1881
EGCTPYDINQML,CLASS-1,,Mamu-A*01,RHUESUS,VIRAL,P05893,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
EGGVGWRHW,CLASS-1,HLA-B44,B*4403,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF VIROLOGY 1996 70 2394-2402
EGILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
EGNASRCWVA,CLASS-1,Patr-B16,B*1601,CHIMPANZEE,VIRAL,P27957,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 669-676
EGRAWAQPGYPWPLYGNEGL,CLASS-1,H-2d,,MOUSE,VIRAL,P27959,Uniprot,JOURNAL OF GENERAL VIROLOGY 1999 80 187-193
EGSRNQDWL,CLASS-1,H-2b,H-2Db,MOUSE,CANCER,Q60696,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 188 277-286
EICTEMEKEGKISKIGP,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P05961,Uniprot,PROC.NATL.ACAD.SCI. USA 1990 87 2344-2348
EIDLRQMRTVTPIRMQGGCGSCWAFSGVA,CLASS-1/2,H-2b,,MOUSE,ALLERGEN,P08176,Uniprot,INTERNATIONAL IMMUNOLOGY 1999 11 1927-1933
EIKDTKEAL,CLASS-1,HLA-B8; HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1994 269 32426-32434; PROC.NATL.ACAD.SCI. USA 1990 87 7045-7049
EILGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
EIYKRWII,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 1515-1521
EIYKRWIIL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1994 269 32426-32434
ELAGIGILTV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF IMMUNOLOGY 1998 160 1750-1758
ELKKKYGI,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,P07108,Uniprot,IMMUNOGENETICS 1998 48 56-61
ELKRKMIYM,CLASS-1,HLA-B8,,HUMAN,VIRAL,P13202,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
ELKSRYWAI,CLASS-1,HLA-B8,,HUMAN,VIRAL,P26065,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
ELNEALELK,CLASS-1,HLA-A11,A*1101,HUMAN,CANCER,Q00366,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221
ELQLLMQSTPPTNNR,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03420,Uniprot,JOURNAL OF GENERAL VIROLOGY 2002 83 429-438
ELRGRAYGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 191-195
ELRSRYWAI,CLASS-1,HLA-B8,,HUMAN,VIRAL,P03467,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
ELRSRYWAL,CLASS-1,HLA-B44,,HUMAN,VIRAL,P03467,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
ELTEVFEFA,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06463,Uniprot,VIRUS RESEARCH 1998 54 23-29
ELVSEFSRM,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,J.IMMUNOTH.EMPH.TUMOUR.IMMUNOL. 1995 184 197-209; JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2109-2117
ELVSEFSRV,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
EPEPDVAVL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
EPEPHILLF,CLASS-1,HLA-B53,B*5301,HUMAN,SELF PEPTIDE,P33552,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 367-371
EPIVGAETF,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P03369,Uniprot,AIDS 1996 10 1075-1083
EPIVGAETFY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03369,Uniprot,AIDS 1996 10 1075-1083
EPKDEIVEV,CLASS-1,HLA-B53,,HUMAN,PARASITE,Q9U0N9,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
EPLPQGQLTAY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P03206,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
EQYKFYSV,CLASS-1,H-2b; H-2d; H-2b,H-2Kb; H-2Ld,MOUSE,SELF PEPTIDE,Q62425,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2449-2458; JOURNAL OF IMMUNOLOGY 1998 160 77-86
ERIETRSARHPWR,CLASS-1,HLA-A3,,HUMAN,VIRAL,P08563,Uniprot,VIROLOGY 1997 235 286-292
ERYLKDQQL,CLASS-1,HLA-B14; HLA-B14,,HUMAN,VIRAL,P20871; P19550,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 175 961-971; JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
ESLFRAVITK,CLASS-1,HLA-A11,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
ETFYVDGAANR,CLASS-1,HLA-A26,,HUMAN,VIRAL,P04589,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
ETINEEAAEW,CLASS-1,HLA-A25,,HUMAN,VIRAL,P12493,Uniprot,JOURNAL OF GENERAL VIROLOGY 1996 77 1659-1665
ETIRMKMRWLKEKG,CLASS-1,H-2d,,MOUSE,NEMATODE,P29030,Uniprot,VACCINE 2002 20 3685-3694
ETVSEQSNV,CLASS-1,HLA-A68,A*6802,HUMAN,SELF PEPTIDE,P09445,Uniprot,CANCER RESEARCH 1998 58 5144-5150
EVDPIGHLY,CLASS-1,HLA-A1; HLA-A2; HLA-A1; HLA-A1; HLA-B35; HLA-A1; HLA-A1; HLA-A1,A*0201; B*3501; A*0101,HUMAN,CANCER,P43357,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 179 921-930; JOURNAL OF IMMUNOLOGY 1995 154 3961-3968; PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; TISSUE ANTIGENS 2001 57 103-109; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
EVIPMFSAL,CLASS-1,HLA-A26,,HUMAN,VIRAL,P03350,Uniprot,AIDS 1996 10 1441-1443
EVISCKLIKR,CLASS-1,HLA-A33; HLA-A68,A*3301; A*6801,HUMAN,SELF PEPTIDE,P40126,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 188 1005-1016
EVYDGREHSA,CLASS-1,HLA-A1; HLA-A28,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2928-2936
EYLDDRNTF,CLASS-1,HLA-A24,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
EYLQLVFGI,CLASS-1,HLA-A24,,HUMAN,CANCER,P43356,Uniprot,CLINICAL CANCER RESEARCH 1999 5 2236-2241
EYRGFTQDF,CLASS-1,HLA-A24,,HUMAN,CANCER,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 81 459-466
EYWDGETRKVKAQS,CLASS-1,HLA-A69,,HUMAN,SELF PEPTIDE,P10317,Uniprot,NATURE 1987 330 6150 763-765
EYWDGETRNMKASA,CLASS-1,HLA-A69,,HUMAN,SELF PEPTIDE,P30497,Uniprot,NATURE 1987 330 6150 763-765
FAAGIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2366-2374
FADKPDESTL,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,Q9U6Z1,Uniprot,MOLECULAR IMMUNOLOGY 2001 38 279-287
FAFRDLCIV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03126,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
FAGHNMDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
FALGFFPYL,CLASS-1,HLA-A2,A*0201,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY PAPERS IN PRESS 2001
FAPANYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPDNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPENYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPFNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGAYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGDYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGEYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGFFPYL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9NPA0,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY PAPERS IN PRESS 2001
FAPGFYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGGYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGHYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGIYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGKYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGLYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPAL,CLASS-1,H-2b; H-2b; H-2b; H-2b; H-2b; H-2b; H-2b,H-2Kb; H-2Db,MOUSE,VIRAL,P04857; P06161,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; EURO.JOURNAL OF IMMUNOLOGY 1995 25 3270-3276; JOURNAL OF IMMUNOLOGY 1995 155 2841-2848; JOURNAL OF IMMUNOLOGY 1997 158 4301-4309; IMMUNITY 2001 14 231-242
FAPGNYPDL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPEL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPFL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPGL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPHL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPIL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPKL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPLL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPNL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPPL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPQL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPRL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPSL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPTL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPVL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGNYPYL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGPYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGQYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGRYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGSYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGTYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGVYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPGYYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPHNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPINYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPKNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPLNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPNNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPPNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPQNGQFI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
FAPQNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPRNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPSNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPTNYPDL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAPVNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
FAVTNDGVI,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P19996,Uniprot,INTERNATIONAL IMMUNOLOGY 2001 13 451-458
FAWPLYGNEGCGWAGWLLP,CLASS-1,HLA-A24/B38/B55,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
FDFGLRPSIAYTKSKAKDVE,CLASS-1,H-2d; H2-d,H2-Dd,MOUSE,VIRAL; BACTERIAL,P02931,Uniprot,INFECTION AND IMMUNITY 2000 68 2535-2545
FEANGNLI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P03453,Uniprot,JOURNAL OF VIROLOGY 1991 65 5401-5409
FEANGNLIAPMY,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P03453,Uniprot,JOURNAL OF VIROLOGY 1991 65 5401-5409
FEANGNLIAPMYAFALS,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P03453,Uniprot,JOURNAL OF VIROLOGY 1991 65 5401-5409
FEDLRVLSF,CLASS-1,HLA-B44,B*4402,HUMAN,VIRAL,P26073,Uniprot,BIOCHEMISTRY 1995 34 10130-10138
FEQNTAQA,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,NATURE 1994 369 6475 67-71
FEQNTAQP,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,NATURE 1994 369 6475 67-71
FESTGNLIAPEYGFKIS,CLASS-2; CLASS-1,I-Ad; H-2k,H-2Kk,MOUSE,VIRAL,P03451,Uniprot,NATURE 1989 342 6246 180-182
FEVGATYYFNKNMSTYVDYI,CLASS-1,H2-d,H2-Dd,MOUSE,BACTERIAL,P02931,Uniprot,INFECTION AND IMMUNITY 2000 68 2535-2545
FEVGATYYFNKNMSTYVDYII,CLASS-1,H-2d,,MOUSE,VIRAL,P02931,Uniprot,INFECTION AND IMMUNITY 2000 68 2535-2545
FEVRVCACPG,CLASS-1,HLA-B44; HLA-B40,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
FFFDIDLLL,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
FGILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
FGISNYCQI,CLASS-1,H-2b,H-2Db,MOUSE,ALLERGEN,P08176,Uniprot,INTERNATIONAL IMMUNOLOGY 1997 9 273-280
FGNTLTCYLKATAAIRAAGL,n/a; CLASS-1,HLA-A31/A33/B38/B14,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
FGPAHAAAL,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P27599,Uniprot,VACCINE 1999 17 686-694
FIAGNSAYEYV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P06473,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587; JOURNAL OF IMMUNOLOGY 1993 150 4659-4671
FIDSYICQV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06473,Uniprot,IMMUNITY 1997 6 273-281
FIFQSSMTK,CLASS-1,HLA-A3,A*0301,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
FIKEKGGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05860,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 515-521
FILVNLLIFH,CLASS-1,HLA,,HUMAN,PARASITE,not applicable,Uniprot,PARASITE IMMUNOLOGY 2000 22 469-473
FIMIVGGLV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P04579,Uniprot,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
FIRGRAYGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 191-195
FISAVVGIV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544
FIYAGSLSA,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P31952,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
FLALIICNA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
FLCKQYLNL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
FLCWGPFFL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
FLDQVPFSV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
FLEGNEVGKTY,CLASS-1,HLA-A1,,HUMAN,CANCER,Q9NVH9,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 2871-2877
FLGGTRVCL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P31873,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
FLKEKGGL,CLASS-1,HLA-B8; HLA-B8; HLA-B8,,HUMAN,VIRAL,P18801; P03404,Uniprot,PROC.NATL.ACAD.SCI. USA 1997 94 1890-1895; JOURNAL OF VIROLOGY 1994 68 7336-7343; JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
FLKEKGGLEGL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03404,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
FLKEPVHGV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P20892,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 8166-8170
FLLALLSCL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,VIROLOGY 1999 257 177-190
FLLLADARV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P27958,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
FLLMWITQV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P78358,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
FLLSLGIHL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03156; P12933,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534; EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; JOURNAL OF CLINICAL INVESTIGATION 1996 97 1655-1665; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
FLLTRILTI,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P31868; P03140; P31873,Uniprot,NATIONAL MEDICINE 1996 2 1104-1108; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; JOURNAL OF CLINICAL INVESTIGATION 1996 97 1655-1665
FLLTRILTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P31873,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
FLNQTDETL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
FLPSDFFPSV,CLASS-1,HLA-A2; HLA-A68; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201; A*6801; A*0206; A*0205; A*0202,HUMAN,VIRAL,P03146; Q05495; P17391,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 685-693; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; JOURNAL OF CLINICAL INVESTIGATION 1996 97 1655-1665; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
FLQSRPEPT,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03349,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2697-2703
FLRGRAYGI,CLASS-1,HLA-B8; HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
FLRGRAYGL,CLASS-1,HLA-B8; HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,IMMUNOLOGY 1993 79 171-173; EURO.JOURNAL OF IMMUNOLOGY 1992 22 191-195
FLSAVVGIL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544
FLSAVVGILV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544
FLSAVVGIV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544
FLSFHISNL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
FLSLGLVSL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
FLTPKKLQCV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P07288,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 3186-3194
FLWGFFPVL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9NPA0,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY PAPERS IN PRESS 2001
FLWGFFPYL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9NPA0,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY PAPERS IN PRESS 2001
FLWGPRALV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201; A*0209; A*0207,HUMAN,CANCER,P43357,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3038-3043; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
FLWGPRAYA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,O15479,Uniprot,CANCER RESEARCH 1998 58 2969-2972
FLYALALLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF VIROLOGY 2003 77 2757-2761
FLYGALLLA,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P06905,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 10859-10863
FMFGQKLNV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P14866,Uniprot,CANCER RESEARCH 2001 61 2038-2046
FMGHNANTM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
FMNKFIYEI,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P02771,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 5300-5308
FMPHNAFWM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
FMQLIYDSSL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
FNCGGEFFY,CLASS-1,HLA-A29,,HUMAN,VIRAL,P12490,Uniprot,JOURNAL OF VIROLOGY 1997 71 1256-1264
FPRIWLHGL,CLASS-1,HLA-B81; HLA-B7,B*8101; B*0702,HUMAN,VIRAL,P05926,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
FPRIWLHSLG,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12519,Uniprot,VACCINE 2001 19 4385-4395
FPSDSWCYF,CLASS-1,HLA-B35; HLA-B35,B*3503; B*3501,HUMAN,CANCER,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 186 785-793; JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
FPVIFGKASESLKMIF,CLASS-1,HLA-B37,B*3701,HUMAN,CANCER,P43358,Uniprot,TISSUE ANTIGENS 2002 60 365-371
FPVRPQVPL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P24741,Uniprot,AIDS 1996 10 1075-1083
FPVTPQVPL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P05860,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221
FPVTPQVPLR,CLASS-1,HLA-B7,,HUMAN,VIRAL,P05860,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221
FQDAYNAAGGHNAVFN,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,P31952,Uniprot,INFECTION AND IMMUNITY 1999 67 4312-4319
FQGHNDRVM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
FQPQNAQFI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
FQPQNGAFI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
FQPQNGQFI,CLASS-1,H-2b; H-2b; H-2b; H-2b; H-2b; H-2b,H-2Db; H-2Kb,MOUSE,VIRAL,P09992; P09991,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; JOURNAL OF VIROLOGY 1992 66 2527-2531; JOURNAL OF IMMUNOLOGY 1998 161 5087-5096; JOURNAL OF VIROLOGY 1995 69 2297-2305; JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
FQQLFLNTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06788,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2003 104 345-353
FRDLCIVY,CLASS-1,HLA-B18,,HUMAN,VIRAL,P03126,Uniprot,IMMUNOLOGY 1991 72 3-9
FRDYVDRFYK,CLASS-1,HLA-B18; HLA-A68,B*1801; A*6802,HUMAN,VIRAL,P05888; P05889,Uniprot,AIDS 1998 12 1561-1563; JOURNAL OF CLINICAL INVESTIGATION 1998 102 1758-1765
FRKAQIQGL,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03204,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
FRNLAYGRTCVLGKE,CLASS-1,HLA-Cw3,,HUMAN,VIRAL,P03191,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617
FRYWAIRTR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P26089,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
FSLHNEMYI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
FSRVVHLYRNG,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,Q61885,Uniprot,INTERNATIONAL IMMUNOLOGY 2003 15 261-268
FVDYNFTIV,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P18269,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
FVNHDFTVV,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,not applicable,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
FVTWHRYHL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
FVWLHYYSV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
FYCKMNWFL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P08810,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
FYIQMCTEL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,Q07539,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1507-1515
GAFLTNVPY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03409,Uniprot,VIROLOGY 1996 226 102-112
GAGIGVAVL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06475,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
GAGIGVLTA,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P45796,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
GAGYNLDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
GALGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03488,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
GAVQNEITL,CLASS-1,Patr-B*1701; Patr-B*1701; Patr-B*1701,,CHIMPANZEE,VIRAL,P26664; Q00269,Uniprot,IMMUNITY 1999 10 439-449; IMMUNITY 2001 15 883-895
GAYEFTTL,CLASS-1,H-2b,H-2Kb,MOUSE,BACTERIAL,P17103,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2449-2458
GAYMSKAHGV,CLASS-1,HLA-A11,,HUMAN,VIRAL,P27958,Uniprot,CELLULAR IMMUNOLOGY 2000 203 111-123
GDASRCWVA,CLASS-1,Patr-B16,,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 669-676
GDFDSVIDC,CLASS-1,Patr-B*1601,Patr-A*04; Patr-B*16,CHIMPANZEE,VIRAL,P26664; P26663,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 663-668; IMMUNITY 2001 15 883-895
GDYKLVEI,CLASS-1,Mamu-A*11,,RHESUS,VIRAL,P05885,Uniprot,NATURE MEDICINE 1999 5 1270-1276
GDYVFDRI,CLASS-1,H-2b,H-2Kb,MOUSE,BACTERIAL,Q9XBF4,Uniprot,INFECTION AND IMMUNITY 2002 70 3336-3343
GEFAPGNYPALWSY,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,NATURE 1991 350 6320 703-706
GEISPLPSL,CLASS-1,HLA-B44,B*4402,HUMAN,VIRAL,P03496,Uniprot,BIOCHEMISTRY 1995 34 10130-10138
GEIYKRWII,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
GEIYKRWIL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05888,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1994 269 32426-32434
GELGFVFTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,IMMUNOLOGY 1994 82 337-342
GFADLMGYIPL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
GGILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
GGKKKYKL,CLASS-1,HLA-B8; HLA-B8; HLA-B8,,HUMAN,VIRAL,P03348; P03349; P04591,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453; EURO.JOURNAL OF IMMUNOLOGY 1993 23 1999-2004; IMMUNOLOGY LETTERS 2001 79 93-96
GGKKKYKLK,CLASS-1,HLA-B8,,HUMAN,VIRAL,P03348,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
GGLGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05777,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
GGPINMDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
GHRMAWDM,CLASS-1,H-2d,,MOUSE,VIRAL,P27953,Uniprot,HEPATOLOGY 1997 25 470-477
GHRMAWDW,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P27953,Uniprot,VIROLOGY 2000 273 120-126
GIAGGLALL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P16893,Uniprot,LANCET 1995 345 8956 1003-1007
GIFQSSMTK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
GIGGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05775,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
GIGIGVLAA,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P10228,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
GIGILTVIL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
GIKGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,Q9UPH8,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GILGFVFT,CLASS-1,HLA-A2; HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 4047-4053; JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GILGFVFTA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GILGFVFTL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A1,A*0206; A*0211; A*0201; A*0204,HUMAN,VIRAL,P21429,Uniprot,HUMAN IMMUNOLOGY 1994 39 155-162; JOURNAL OF IMMUNOLOGY 1996 156 3882-3891; HUMAN IMMUNOLOGY 1993 37 252-258; NATURE 1991 351 6324 290-296; IMMUNOLOGY 1994 82 337-342; INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396; JOURNAL OF IMMUNOLOGY 1992 149 3580-3587; PARASITE IMMUNOLOGY 2000 22 501-514; INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544; HUMAN IMMUNOLOGY 2001 62 791-798; VACCINE 2001 19 4121-4129
GILGFVFTLT,CLASS-1,HLA-A2; HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 4047-4053; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440
GILGFVFTLTV,CLASS-1,HLA-A69; HLA-A2; HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,NATURE 1989 337 6208 653-655; JOURNAL OF IMMUNOLOGY 1991 147 4047-4053; JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GILGFVFTM,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,IMMUNOLOGY 1994 82 337-342
GILGFVFTV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,IMMUNOLOGY 1994 82 337-342
GILKFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GILTVILGV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
GILTVSVAV,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P30223,Uniprot,JOURNAL OF INFECTIOUS DISEASES 2002 186 991-998
GIMGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05775,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
GITKPAIRRLARRGGVKRIS,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
GIVGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05775,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258
GIWGCSGKLICTAV,CLASS-1,HLA-B17,,HUMAN,VIRAL,P35961,Uniprot,JOURNAL OF VIROLOGY 1996 70 8468-8476
GKFLPEDIPKGL,CLASS-1,H-2d,,MOUSE,NEMATODE,P29030,Uniprot,VACCINE 2002 20 3685-3694
GKKKYKLKH,CLASS-1,HLA-B8,,HUMAN,VIRAL,P03348,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
GKLGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05775,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GLAPPQHLI,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
GLAPPQHLIRV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
GLAVLAAFL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16790,Uniprot,CANCER RESEARCH 1999 59 5554-5559
GLCTLVAML,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,Q04360,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
GLDVLTAKV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P18206,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2509-2516
GLFLSLGLV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
GLGWVGWLL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF MEDICAL VIROLOGY 1999 58 239-246
GLHCYEQLV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06464,Uniprot,IMMUNOLOGY 1994 81 222-227
GLLFAVTSV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16790,Uniprot,CANCER RESEARCH 1999 59 5554-5559
GLLFLHTRT,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P00540,Uniprot,CANCER RESEARCH 2001 61 2038-2046
GLLGFVFTL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03487; P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
GLLNKLENI,CLASS-1,HLA-A2,,HUMAN,PARASITE,Q9U0N9,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
GLNKIVRMY,CLASS-1,HLA-B62,,HUMAN,VIRAL,P05889,Uniprot,IMMUNOLOGY LETTERS 2001 79 93-96
GLQDCTMLV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26664,Uniprot,JOURNAL OF VIROLOGY 1995 69 2462-2470; JOURNAL OF CLINICAL INVESTIGATION 1997 100 2376-2385; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230
GLRDLAVAVEPV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
GLSPNLNRFL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P02771,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 5300-5308
GLSPTVWLSV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03156; P31873,Uniprot,JOURNAL OF IMMUNOLOGY 1993 150 4659-4671; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
GLSRYVARL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201; A*0202,HUMAN,VIRAL,P03156; P03155,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534; EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; JOURNAL OF CLINICAL INVESTIGATION 1996 97 1655-1665; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
GLVSLVENA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
GLYDGMEHL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P43363,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6849-6854
GLYSSTVPV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
GMLGFVFTL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258; IMMUNOLOGY 1994 82 337-342
GMSWNMDFI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
GNASPCWVA,CLASS-1,Patr-B16,B*1601,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 669-676
GNASRCWVA,CLASS-1,Patr-B16,Patr-B*16; B*1601,CHIMPANZEE,VIRAL,P27958; P26664,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1761-1775; JOURNAL OF IMMUNOLOGY 1999 162 669-676
GNWAKVLVVL,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P27956,Uniprot,IMMUNITY 2001 15 883-895
GPCKNVSTVQ,CLASS-1,HLA-B56,,HUMAN,VIRAL,P12491,Uniprot,VACCINE 2001 19 4385-4395
GPGHKARVL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12493,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 1515-1521
GPGRAFVTI,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P04624,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 2777-2781
GPKESKKKVE,CLASS-1,HLA-B58,,HUMAN,VIRAL,P12507,Uniprot,VACCINE 2001 19 4385-4395
GPKVKQWPLT,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12499,Uniprot,VACCINE 2001 19 4385-4395
GPPHSNNFGY,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P10238,Uniprot,IMMUNOGENETICS 1993 37 135-138
GPRLCVRAT,CLASS-1,HLA-B7,,HUMAN,VIRAL,P26664,Uniprot,CELLULAR IMMUNOLOGY 2000 203 111-123
GPRLGVRAT,CLASS-1,HLA-B7; HLA-B7; HLA-B7; HLA-B7,,HUMAN; MOUSE,VIRAL,P26664; P27959,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; JOURNAL OF VIROLOGY 1993 67 7522-7532
GPRLGVRATRKTSERSQPRG,n/a; CLASS-1,HLA-A2/A29/B41/B50,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
GQAPGFTY,CLASS-1,H-2b; H-2b,H-2Db; H-2Kb,MOUSE,MISCELLANEOUS,P00004,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2141-2149
GQAPGFTYT,CLASS-1,H-2b; H-2b,H-2Kb; H-2Db,MOUSE,MISCELLANEOUS,P00004,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2141-2149
GQGGSPTAM,CLASS-1,HLA-B15; HLA-B62,B*1501,HUMAN,VIRAL,P03203,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
GQGINNLDNL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,INTERNATIONAL IMMUNOLOGY 1998 10 463-472
GQIVGGVYLLP,CLASS-1,HLA-B60,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF GENERAL VIROLOGY 1996 77 1305-1309
GQLGFVFTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P10918,Uniprot,IMMUNOLOGY 1994 82 337-342
GRAFVTIGK,CLASS-1,HLA-B27; HLA-B27,B*2705,HUMAN,VIRAL,P19551,Uniprot,NATURE 1991 353 6342 326-329; JOURNAL OF VIROLOGY 1993 67 694-702
GRPAVFDRKSDAKST,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03203,Uniprot,JOURNAL OF VIROLOGY 1993 67 1572-1578
GRPKNGCIV,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P23804,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 239-246
GRRGWEALKY,CLASS-1,HLA-B27,,HUMAN,VIRAL,P05878,Uniprot,JOURNAL OF IMMUNOLOGY 1992 148 2738-2747
GSEELRSLY,CLASS-1,HLA-A1,,HUMAN,VIRAL,P05887,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1423-1433
GSPATWTTR,CLASS-1,HLA-A11,A*1101,HUMAN,SELF PEPTIDE,Q01955,Uniprot,KIDNEY INT. 1996 49 1127-1133
GSPHNMDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
GSTHVSWPK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03156,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
GTLGFVFTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,IMMUNOLOGY 1994 82 337-342
GTLGIVCPI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
GVAGALVAFK,CLASS-1,HLA-A11; HLA-A3,,HUMAN,VIRAL,P27958; P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761; HUMAN IMMUNOLOGY 2003 64 497-504
GVALQTMKQ,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P02771,Uniprot,CANCER RESEARCH 1999 59 3134-3142; JOURNAL OF IMMUNOLOGY 2001 166 5300-5308
GVENPGGYCL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09992,Uniprot,JOURNAL OF VIROLOGY 1992 66 6755-6762
GVETFYVDGA,CLASS-1,HLA-B45,,HUMAN,VIRAL,P04588,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
GVLGFVFTL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P05775,Uniprot,HUMAN IMMUNOLOGY 1993 37 252-258; IMMUNOLOGY 1994 82 337-342
GVLLWEIFSL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
GVLVGVALI,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,P06731,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2216-2225
GVNYATGNL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
GVRVLEDGV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
GVRYPLTFGWCYKLVP,CLASS-1,HLA-B18,,HUMAN,VIRAL,P05855,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
GVSENIFLK,CLASS-1; CLASS-2,HLA; HLA-A11,,HUMAN,PARASITE,not applicable,Uniprot,PARASITE IMMUNOLOGY 2000 22 469-473; JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
GVYDGREHTV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P43358,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1999 29 3329-3337; JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
GWGKYLVGFGRV,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
GYCGLRGTGV,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q92SY7,Uniprot,INTERNATIONAL IMMUNOLOGY 2001 13 625-632
GYKDGNEYI,CLASS-1,H-2d; H-2d,H-2Kd,MOUSE,BACTERIAL,P13128,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; JOURNAL OF VIROLOGY 2000 74 5769-5775
GYKDWILWI,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03442,Uniprot,VIROLOGY 1995 214 445-452
GYNKAMGFL,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q53586,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
GYNKPLCDLL,CLASS-1,H-2b,,HUMAN,VIRAL,P03126,Uniprot,VIRAL IMMUNOLOGY 1999 12 297-312
HAGSLLVFM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P17593,Uniprot,JOURNAL OF VIROLOGY 1997 71 5244-5250
HAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
HAVPFGLVSM,CLASS-1,HLA-A3.14,,HUMAN,VIRAL,P29165,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
HDGAGKRVY,CLASS-1,HLA-A3,,HUMAN,VIRAL,P27958,Uniprot,CELLULAR IMMUNOLOGY 2000 203 111-123
HDGAGKRVYYL,CLASS-1,HLA-B38,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
HEYPVGSQL,CLASS-1,H-2k,,MOUSE,VIRAL,P26664,Uniprot,VACCINE 2000 18 1962-1968
HGILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
HHIWQNLL,CLASS-1,HLA-B39,,HUMAN,VIRAL,P03204http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
HIRGRAYSL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 191-195
HLFGYSWYK,CLASS-1,HLA-A3,A*0301,HUMAN,CANCER,P06731,Uniprot,CANCER RESEARCH 1999 59 431-435
HLGNVKYLV,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P16893,Uniprot,LANCET 1995 345 8956 1003-1007
HLHQNIVDV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
HLLVGSSGL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
HLRGRAYGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 191-195
HLSTAFARV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16790,Uniprot,CANCER RESEARCH 1999 59 5554-5559
HLYQGCQVV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
HLYSHPIIL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,Q05486,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
HMWNFISGI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P27958,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
HNSYNHNIL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,INTERNATIONAL IMMUNOLOGY 1998 10 463-472
HPDIVIYQY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P24740,Uniprot,NATIONAL MEDICINE 1995 1 59-64
HPFALLLVL,CLASS-1,HLA-A3; HLA-A3; HLA-A10,A*0301; A*0302; A*1052,HUMAN,VIRAL,P03314,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
HPKYKTEL,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,P26651,Uniprot,IMMUNOGENETICS 1998 48 56-61
HPLHEQHGM,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 102-110
HPNIEEVAL,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744; JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
HPQKVTKFML,CLASS-1,H-2d,H-2Ld,MOUSE,CANCER,P07288,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2001 256 107-119
HPRVSSEVHI,CLASS-1,HLA-B7,B*0702,HUMAN,VIRAL,P03402,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
HPVGEADYFEY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03211,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
HRCQAIRKK,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03203,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
HSKKKCDEL,CLASS-1,HLA-B8; HLA-B8; HLA-B8,,HUMAN,VIRAL,P26664; P26663,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
HTLWKAGILYK,CLASS-1,HLA-A11; HLA-A11; HLA-A3; HLA-A1,,HUMAN,VIRAL,P03156; P12933,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925; JOURNAL OF IMMUNOLOGY 1997 159 4753-4761; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
HVDIRTLED,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
HVLSHNSYEK,CLASS-1,HLA,,HUMAN,PARASITE,not applicable,Uniprot,PARASITE IMMUNOLOGY 2000 22 469-473
HVQDHALPK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
IAGIGILAI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06024,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
IAKFGTAFKAVN,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
IAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
IASNENMETMESSTL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P15682,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1987 165 1508-1523
IATDFSVIK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
IAVGLLLYCKAR,CLASS-1,HLA-B57,,HUMAN,VIRAL,P03420,Uniprot,JOURNAL OF VIROLOGY 2000 74 10240-10244
ICPMYARV,CLASS-1,H-2b,H-2Kb,MOUSE,BACTERIAL,Q48727,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 968-975
IEDPPFNSL,CLASS-1,HLA-B40; HLA-B60,B*40011,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 3325-3334; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
IEGGWTGMI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P03454,Uniprot,JOURNAL OF VIROLOGY 1991 65 5401-5409
IETRSARHP,CLASS-1,HLA-A3,,HUMAN,VIRAL,P07566,Uniprot,VIROLOGY 1997 235 286-292
IGPGRAFHT,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P03383,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2369-2376
IHDIILECVY,CLASS-1,HLA-B18,,HUMAN,VIRAL,P03126,Uniprot,IMMUNOLOGY 1991 72 3-9
IHSMNSSIL,CLASS-1,HLA-B39,B*3901,HUMAN,VIRAL,P03101http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,ARCHIVES OF VIROLOGY 2002 147 1933-1942
IHSMNSTIL,CLASS-1,HLA-B39,B*3901,HUMAN,VIRAL,P03101,Uniprot,ARCHIVES OF VIROLOGY 2002 147 1933-1942
IIDDVPSPK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
IISALVGIL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
IISALVGIV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
IISAVVGIL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 1115-1123; JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; INTERNATIONAL JOURNAL OF CANCER 2001 94 540-544; PROC.NATL.ACAD.SCI. USA 1995 92 432-436
IISAVVGILL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
IISAVVGIV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
IISFFSPL,CLASS-1,H2-b,H2-Kb,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
IIYDRKFLM,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
IIYIYHRL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3645-3651
IIYQYMDDL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P12499,Uniprot,JOURNAL OF INFECTIOUS DISEASES 1996 173 476-479
IIYRFLLI,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P11853,Uniprot,JOURNAL OF GENERAL VIROLOGY 1993 74 2579-2586
ILAGYGAGV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26663; P26664,Uniprot,JOURNAL OF VIROLOGY 1995 69 2462-2470; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230
ILAKFLHWL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,O14746,Uniprot,IMMUNITY 1999 10 673-679
ILDEAYVMA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
ILDSFDPLV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 95 521-530; EURO.JOURNAL OF IMMUNOLOGY 1995 25 627-630; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123
ILGELREKV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
ILGFVFTLFV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF VIRAL HEPATITIS 2002 9 18-28
ILGFVFTLT,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,IMMUNOLOGY 1994 82 337-342; JOURNAL OF IMMUNOLOGY 1991 147 4047-4053
ILGFVFTLTV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 4047-4053; NATURE 1991 351 6324 290-296
ILGLNKIVRMY,CLASS-1,HLA-B15; HLA-B62,B*1501,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF VIROLOGY 1993 67 694-702
ILHNGAYSL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
ILHTPGCV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27956; P27954,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
ILKEPVHGV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A1; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL; CANCER,P03368; P20892; P04637; P12499; P04589,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587; PROC.NATL.ACAD.SCI. USA 1993 90 10275-10279; NATURE 1991 351 6324 290-296; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925; PROC.NATL.ACAD.SCI. USA 1991 88 11276-11280; PROC.NATL.ACAD.SCI. USA 1995 92 8166-8170; PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997; VACCINE 2001 19 4121-4129; VACCINE 2003 21 1502-1509; JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1423-1433
ILMEHIHKL,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,P14118,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2216-2225
ILNHNFCNL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P07399,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1998 28 3301-3311
ILPRKHHRI,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P51815,Uniprot,CANCER RESEARCH 2001 61 2038-2046
ILRGSVAHK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P15663,Uniprot,JOURNAL OF IMMUNOLOGY 1993 151 5930-5935
ILSALVGIL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
ILSALVGIV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
ILSAVVGIL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449; JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
ILSAVVGIV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
ILSPFLPV,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03140,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1998 28 4149-4161
ILTVILGVL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 363-368; JOURNAL OF IMMUNOLOGY 1995 154 2257-2265; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
ILYFIAFAL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
IMDKNIILKA,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03496,Uniprot,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
IMIKFNRL,CLASS-1,H-2b,H-2Kb,MOUSE,SELF PEPTIDE,P05455,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 1000-1005
IMPKAGLLI,CLASS-1,HLA-A24; HLA-A24,,HUMAN,CANCER,P43357,Uniprot,CANCER RESEARCH 1997 57 4465-4468; CORNEA 2000 19 S2-S6
IMSRDLVPRI,CLASS-1,HLA-A2,,HUMAN,n/a,not applicable,Uniprot,BRITISH JOURNAL OF CANCER 2002 87 1006-1012
INGLPVSARR,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 1999 10 439-449
INGLPVSARRGREIL,CLASS-1,Patr-A*0402,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 2001 15 883-895
INYEYAIV,CLASS-1,H-2b,H-2Kb,MOUSE,BACTERIAL,P15712,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 1997 45 521-526
IPAETGQETA,CLASS-1,HLA-B56,,HUMAN,VIRAL,P12499,Uniprot,VACCINE 2001 19 4385-4395
IPGLPLSL,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,P31748,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 1599-1607
IPLTEEAEL,CLASS-1,HLA-B51; HLA-B35; HLA-B35; HLA-B51,B*5101; B*3501,HUMAN,VIRAL,P03368,Uniprot,AIDS 1996 10 1075-1083
IPQQHTQVL,CLASS-1,HLA-B7,,HUMAN,CANCER,P06731,Uniprot,CANCER RESEARCH 2000 60 5223-5227
IPQSLDSWWTSL,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,VIRAL,P03140; P31873,Uniprot,VACCINE 2000 18 2878-2885; EURO.JOURNAL OF IMMUNOLOGY 1998 28 4149-4161
IPSINVHHY,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P06725; P18139,Uniprot,JOURNAL OF IMMUNOLOGY 1993 151 3971-3980; BLOOD 2001 98 1872-1881
IPVIVADDL,CLASS-1,HLA-A3,A*03013,HUMAN,VIRAL,P03314,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
IPYIYNTL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3645-3651
IQRGPGRAFV,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P04624,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 1973-1986
IQVGNTRTI,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P08538,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 1603-1612
IRDAVTYTEHAKRKTVTA,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
IRFPKTFGW,CLASS-1,Mamu-B*17,,RHESUS,VIRAL,P31818,Uniprot,NATURE MEDICINE 1999 5 1270-1276
IRLRPGGKK,CLASS-1,HLA-B27,,HUMAN,VIRAL,P18800,Uniprot,NATURE 2001 412 334-338
ISEYRHYCY,CLASS-1,HLA-B18; HLA-B18,,HUMAN,VIRAL,P03126,Uniprot,IMMUNOLOGY 1991 72 3-9; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2281-2289
ISKKAKGWF,CLASS-1,HLA-B57,B*5701,HUMAN,VIRAL,Q73455,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
ISNQEPLKL,CLASS-1,HLA-A1,,HUMAN,VIRAL,P05133,Uniprot,JOURNAL OF VIROLOGY 1999 73 5301-5308
ISPRTLNAW,CLASS-1,HLA-B57; HLA-B57,B*5701,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 2191-2201
ISTQNHRAL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,CELL 1989 58 293-303
ISTQNHRALDLV,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,CELL 1989 58 293-303
ISTQNHRALDLVAA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,CELL 1989 58 293-303
ISTQNHRALDLVAAK,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,CELL 1989 58 293-303
ITDOVPFSV,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,P40967,Uniprot,CORNEA 2000 19 S2-S6
ITDQVPFSV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 82 669-677; JOURNAL OF IMMUNOLOGY 1996 157 2539-2548; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CELLULAR IMMUNOLOGY 2000 204 29-37
ITLEDSSGNL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
ITLWQRPLV,CLASS-1,HLA-A68; HLA-B18,A*6802,HUMAN,VIRAL,P12498,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1758-1765
IVADFSVIK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
IVDCCLTEMY,CLASS-1,HLA-A1,A*0101,HUMAN,SELF PEPTIDE,O00507,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 6360-6364
IVGLNKIVR,CLASS-1,HLA-A33,A*3303,HUMAN,VIRAL,P04592,Uniprot,JOURNAL OF VIROLOGY 1993 67 694-702
IVLPEKDSW,CLASS-1,HLA-B57,B*5701,HUMAN,VIRAL,P05959,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 2191-2201
IVLSGSGKSM,CLASS-1,HLA-A26,A*2601,HUMAN,CANCER,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 277-288
IVQEEGTVTEE,CLASS-1,H-2k/d,,MOUSE,PARASITE,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 379-389
IVRDFSVIK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03203,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221
IVTDFAVIK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P03203,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 927-938
IVTDFSVIK,CLASS-1,HLA-A11; HLA-A11; HLA-A11,A*1101,HUMAN,VIRAL,P03203; P03211,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221; JOURNAL OF VIROLOGY 1993 67 1572-1578; JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
IVTDFSVIKAIEEE,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03203,Uniprot,JOURNAL OF VIROLOGY 1993 67 1572-1578
IVTDFSVIR,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03203,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221
IVYEAADAI,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
IYKQSQHM,CLASS-1,HLA-A24,,HUMAN,SELF PEPTIDE,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
IYQKANTFL,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,P39682,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
IYSTVASSL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03455,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1507-1515
IYTQNRRAL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,not applicable,Uniprot,INTERNATIONAL IMMUNOLOGY 1993 5 1489-1492
IYTQNRRALDL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,not applicable,Uniprot,SEMIN.IMMUNOLOGY 1993 5 95-104
IYVGNGQMINAQ,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
IYVLVMLVL,CLASS-1,HLA-A2,A*2402,HUMAN,VIRAL,P13285,Uniprot,BLOOD 2003 101 1460-1468
IYVYALPLKM,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
IYYNVNVNRPTR,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
KAAFDAAVSGKS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
KAAYNFATM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF VIROLOGY 2001 75 5099-5107
KACDPHSGHFV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P11802,Uniprot,SCIENCE 1995 269 5228 1281-1284
KAFSPEVI,CLASS-1,HLA-B57,,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF VIROLOGY 2000 74 5291-5299
KAILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KALYNFATM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
KARDPHSGHFV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P11802,Uniprot,SCIENCE 1995 269 5228 1281-1284
KASEKIFYV,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,Q16385,Uniprot,JOURNAL OF IMMUNOLOGY 2002 168 1717-1722
KAVANFATM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KAVFNFATM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KAVSNFATM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KAVYNFATC,CLASS-1,H-2b; H-2b; H-2b; H-2b; H-2b; H-2b,H-2Db; H-2Kb,MOUSE,VIRAL,P09991,Uniprot,SCIENCE 1994 263 5153 1615-1618; VIROLOGY 1997 234 62-73; JOURNAL OF IMMUNOLOGY 1998 161 5087-5096; JOURNAL OF VIROLOGY 1995 69 2297-2305; JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KAVYNFATCG,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,VIROLOGY 1990 178 393-400
KAVYNFATCGI,CLASS-1,H-2b; H-2b; H-2b,H-2Db; H-2Kb,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF VIROLOGY 1995 69 2297-2305; VIROLOGY 1997 234 62-73; JOURNAL OF VIROLOGY 2001 75 5099-5107
KAVYNFATM,CLASS-1,H-2b; H-2b; H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF VIROLOGY 2001 75 5099-5107; JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885; JOURNAL OF IMMUNOLOGY 2000 164 3645-3651
KAVYNYASM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
KCDDVLLLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03070,Uniprot,CANCER RESEARCH 2001 61 873-879
KCDICTDEY,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P14679,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 2099-2106
KDIGNIISDA,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P18687,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 451-458
KDILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KDSWTVNDIQKLVGK,CLASS-2; CLASS-1,I-Ad; I-Ed; HLA-A2,,MOUSE; HUMAN,VIRAL,P05959,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 1496-1502; VACCINE 2003 21 1502-1509
KDTWLDARM,CLASS-1,,,HUMAN,VIRAL,Q04360,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617
KEHVIQNAF,CLASS-1,HLA-B44,B*4402,HUMAN,VIRAL,P03204,Uniprot,SEMIN.IMMUNOLOGY 1992 4 97-104
KEILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KEKGGLEGL,CLASS-1,HLA-B60,,HUMAN,VIRAL,P18801,Uniprot,JOURNAL OF VIROLOGY 2000 74 8541-8549
KFHRVIKDF,CLASS-1,HLA-A24; HLA-A24,A*2402,HUMAN,SELF PEPTIDE,P45877; P23284,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 4994-5004; JOURNAL OF IMMUNOTHERAPY 2002 25 439-444
KFILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGALGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGELGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGFLGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGDVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFGLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTETV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTFTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTLAV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTLDV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTLTK,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTLTV,CLASS-1,HLA-A69; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P10918; P03495; P21429,Uniprot,NATURE 1989 337 6208 653-655; JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 931-936; JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
KGILGFVFTRTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVFTSTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVNTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGFVSTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGIVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGVVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGILGYVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGINGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGISGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KGSGKMKTE,CLASS-1,HLA-A26,A*2601,HUMAN,CANCER,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 277-288
KGYAWQYT,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
KGYKDGNEYIVV,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
KGYVYQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
KHPDATYSR,CLASS-1,Patr-A*0401; Patr-A*0401,Papa-Q*06; Patr-A*04,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 663-668; JOURNAL OF IMMUNOLOGY 1999 162 669-676; IMMUNITY 2001 15 883-895
KIFGSLAFL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,J.IMMUNOTH.EMPH.TUMOUR.IMMUNOL. 1995 184 197-209; JOURNAL OF IMMUNOLOGY 1999 163 1037-1044; JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2109-2117; JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; HUMAN IMMUNOLOGY 1997 52 109-118
KIIRGSNDK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
KILGFVFTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
KIRLRPGGK,CLASS-1,HLA-A3; HLA-A3; HLA-A3; HLA-A3; HLA-A3,A*0301,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF VIROLOGY 2000 74 7694-7697; JOURNAL OF VIROLOGY 1999 73 3975-3985; JOURNAL OF IMMUNOLOGY 1996 156 2616-2623; NATURE 2001 412 334-338
KKALGFVFTLDK,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1991 139 41-47
KKILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KKKYKLKHI,CLASS-1,HLA-B8,,HUMAN,VIRAL,P03350,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 447-453
KKLDEEALLK,CLASS-1,HLA-A26,A*2601,HUMAN,CANCER,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 277-288
KLCPVQLWV,CLASS-1,HLA-A2,,HUMAN,CANCER,P04637,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
KLEELHENV,CLASS-1,HLA-A2,,HUMAN,PARASITE,Q9U0N9,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
KLFPEVIDL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P18269,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
KLGEFYNQMM,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P13885,Uniprot,MOLECULAR IMMUNOLOGY 1992 29 1131-1140; JOURNAL OF IMMUNOLOGY 1989 143 4098-4103
KLHLYSHPI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
KLIETYFSK,CLASS-1,HLA-A3,,HUMAN,SELF PEPTIDE,P06905,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 1997 73 1-2 7-14
KLILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KLIPNASLIENCTKAEL,CLASS-1,HLA-A2,,HUMAN,VIRAL,not applicable,Uniprot,IMMUNOLOGY AND CELL BIOLOGY 2003 81 67-72
KLKKIKNSI,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P26694,Uniprot,PARASITE IMMUNOLOGY 2000 22 501-514
KLKKIKNSL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P26694,Uniprot,PARASITE IMMUNOLOGY 2000 22 501-514
KLLMVLMLA,CLASS-1,HLA-A2; HLA-A3,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80; INTERNATIONAL JOURNAL OF CANCER 2002 102 499-506
KLPDLCTEL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03126,Uniprot,VIRUS RESEARCH 1998 54 23-29
KLPQLCTEL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03126,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
KLTPLCVTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P12489,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
KLVALGINAV,CLASS-1; n/a,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26663; P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 95 521-530; JOURNAL OF CLINICAL INVESTIGATION 1997 100 2376-2385; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; HEPATOLOGY 2001 33 1533-1543; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123; JOURNAL OF IMMUNOLOGICAL METHODS 2004 287 91-99; LIVER TRANSPLANTATION 2004 10 217-227; VIRAL IMMUNOLOGY 2001 14 59-69
KLVGKLNWA,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P04588,Uniprot,HUMAN IMMUNOLOGY 1997 52 109-118
KLWESPQEI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P35977,Uniprot,JOURNAL OF VIROLOGY 2003 77 5014-5016
KMVELVFL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P43356,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1997 73 125-130
KNCGGEFFYCNS,CLASS-1,HLA-A2,,HUMAN,VIRAL,P35961,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
KNKEKALI,CLASS-1,HLA-B8,,HUMAN,PARASITE,P16893,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1435-1445
KNKEKALII,CLASS-1,HLA-B8,,HUMAN,PARASITE,P16893,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1435-1445
KNMSTYVDYIINQIDSDNKL,CLASS-1,H-2d; H2-d,H2-Dd,MOUSE,VIRAL; BACTERIAL,P02931,Uniprot,INFECTION AND IMMUNITY 2000 68 2535-2545
KNYIFEEKL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 868-874
KPCVKLTPLC,CLASS-1,UNKNOWN,,HUMAN,VIRAL,P35961,Uniprot,VACCINE 2001 19 4385-4395
KPKDELDY,CLASS-1,HLA-B35,,HUMAN,PARASITE,P04923,Uniprot,NATURE 1992 360 6403 434-439
KPKDELDYENDIEKKICKMEKCSC,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P04923,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244
KPNDKSLY,CLASS-1,HLA-B35,,HUMAN,PARASITE,P13814,Uniprot,NATURE 1992 360 6403 434-439
KPPLPSVKKL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P35964,Uniprot,VACCINE 2001 19 4385-4395
KPPLPSVTKL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P35964,Uniprot,VACCINE 2001 19 4385-4395
KPVVSTQLLL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12491,Uniprot,VACCINE 2001 19 4385-4395
KQILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KQIYYNVNVNEP,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
KQYQKSTER,CLASS-1,HLA-B27,,HUMAN,SYNTHETIC,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 2750-2759
KRKMIYMCY,CLASS-1,HLA-B27,,HUMAN,VIRAL,P13202,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
KRPPIFIRR,CLASS-1,HLA-B2705,,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
KRQQELLRL,CLASS-1,Mamu-B*03,,RHESUS,VIRAL,P05885,Uniprot,NATURE MEDICINE 1999 5 1270-1276
KRVVINKDT,CLASS-1,HLA-B27,,HUMAN,BACTERIAL,O66200,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 1529-1537
KRWIILGLN,CLASS-1,HLA-B27,B*2702,HUMAN,VIRAL,P05888,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2189-2197
KRWIILGLNK,CLASS-1,HLA-B27; HLA-B27; HLA-B27; HLA-B27; HLA-B27; HLA-B27; HLA-B27,B*2705; B*2703,HUMAN,VIRAL,P05888; P05889,Uniprot,JOURNAL OF VIROLOGY 1993 67 694-702; INTERNATIONAL IMMUNOLOGY 1990 2 311-316; NATURE 2001 412 334-338; JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
KRYWAIRTR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P26089,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
KSDNQIKAVPASQAL,CLASS-1,H-2K,,MOUSE,WORM,P12812,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 5420-5427
KSILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
KSKDELDY,CLASS-1,HLA-B35,,HUMAN,PARASITE,P13814,Uniprot,NATURE 1992 360 6403 434-439
KSKKTPMGF,CLASS-1,HLA-B57,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
KSLYDEHI,CLASS-1,HLA-B17,,HUMAN,PARASITE,not applicable,Uniprot,LANCET 1995 345 8956 1003-1007
KSPWFTTL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03386,Uniprot,JOURNAL OF IMMUNOLOGY 1994 152 106-116
KTCPVQLWV,CLASS-1,HLA-A2,,HUMAN,CANCER,P04637,Uniprot,SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2001 53 357-364
KTGGPIYKR,CLASS-1,HLA-A68,A*6801,HUMAN,VIRAL,Q08034,Uniprot,NATURE 1992 360 6402 364-366
KTSERSQPR,CLASS-1,HLA-A3,,HUMAN,VIRAL,P27959,Uniprot,HUMAN IMMUNOLOGY 2003 64 497-504
KTWGOYWQV,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,P40967,Uniprot,CORNEA 2000 19 S2-S6
KTWGQYWQV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 82 669-677; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CELLULAR IMMUNOLOGY 2000 204 29-37
KTWGQYWQVL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
KVDDTFYYV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P17363,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2003 197 927-932
KVIDTLTCGFADLMGYIPLV,CLASS-1,H-2d; H-2b; H-2r,,MOUSE,VIRAL,P27954,Uniprot,MOLECULAR IMMUNOLOGY 1996 33 703-709
KVLFLDGIDK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03368,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
KVPRNQDWL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P40967,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 188 277-286
KVVRFDKL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,P01012,Uniprot,NATURE IMMUNOLOGY 2000 1 145-150
KVYLAWVPAHK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03368,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
KWVPGAVYTFY,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 1999 10 439-449
KWVPGAVYTFYG,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 2001 15 883-895
KYAQAYPNVSAK,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
KYGVSVQDI,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 1994 152 686-694
KYHRVIKDF,CLASS-1,HLA-A24,A*2402,HUMAN,SELF PEPTIDE,P45877,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 4994-5004
KYKNAVTEL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P13843,Uniprot,JOURNAL OF IMMUNOLOGY 2002 169 3208-3216
KYLKKIKNSL,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P13814,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 4134-4141
KYMCNSSCM,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,CANCER,P02340,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2635-2639; JOURNAL OF IMMUNOLOGY 1996 157 239-246
KYNKANWFL,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q44716,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
KYNKNGNFL,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q44716,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
KYQAVTTTL,CLASS-1,H-2d; H-2d,H-2Kd,MOUSE,SELF PEPTIDE; n/a,P19253; not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612; INTERNATIONAL IMMUNOLOGY 2001 13 625-632
KYQAVTTTLE,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P19253,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
KYQAVTTTLEE,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P19253,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
KYTAFTIPSI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03368,Uniprot,JOURNAL OF ACQUIRED IMMUN.DEF.SYN.HUM.RET. 1998 19 111-120
KYVFAKAGISLP,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
LAAQERRVPR,CLASS-1,HLA-A31; HLA-A31,,HUMAN,CANCER,P78358; O95146,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
LAAVVGLSAGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LAAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LACAGLAYK,CLASS-1,HLA-A11,,HUMAN,PARASITE,P16893,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
LADQLIHLHY,CLASS-1,HLA-B18,B*1801,HUMAN,VIRAL,P03402,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
LAGIGLIAA,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P46104,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
LAMLDLLHV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
LAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
LAYLGWLVF,CLASS-1,H-2d,H-2Ld,MOUSE,CANCER,P19473,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
LDRLVRLI,CLASS-1,H-2k; H-2k; H-2k,H-2Kk,MOUSE,VIRAL,P04851,Uniprot,VIROLOGY 1994 203 172-177; JOURNAL OF GENERAL VIROLOGY 2000 81 2707-2713; VIROLOGY 1994 203 172-777
LEKARGSTY,CLASS-1,HLA-B15; HLA-B62,B*1501,HUMAN,VIRAL,P12977,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
LELRSRYWA,CLASS-1,HLA-B44,B*4402,HUMAN,VIRAL,P26073,Uniprot,BIOCHEMISTRY 1995 34 10130-10138
LEWRFDSRL,CLASS-1,HLA-B44,,HUMAN,VIRAL,P05855,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
LFAAFPSFA,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P30223,Uniprot,JOURNAL OF INFECTIOUS DISEASES 2002 186 991-998
LFCASDAKAY,CLASS-1,HLA-A24,,HUMAN,VIRAL,P12488,Uniprot,JOURNAL OF IMMUNOLOGY 1992 148 2738-2747
LGAFFSIL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P05133,Uniprot,JOURNAL OF MEDICAL VIROLOGY 2000 60 189-199
LGAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LGFGAYMSK,CLASS-1,HLA-A3; HLA-A3,,HUMAN,VIRAL,P26663; P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689; HUMAN IMMUNOLOGY 2003 64 497-504
LICPAGHAV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440
LIFCHSKKK,CLASS-1,HLA-A3; HLA-A3; HLA-A3,,HUMAN,VIRAL,P26663; P26664,Uniprot,VIROLOGY 1998 251 132-140; HUMAN IMMUNOLOGY 2003 64 497-504; LIVER TRANSPLANTATION 2004 10 217-227
LIGNESFAL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
LIPETVPYI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
LIRVEGNLORV,CLASS-1,HLA-B51,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
LIVIGILIL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P17592,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
LIYDSSLCDL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
LIYEFNTL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3645-3651
LIYIFNTL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3645-3651
LIYRRRLMK,CLASS-1,HLA-A3; HLA-A3,,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6985-6992; CORNEA 2000 19 S2-S6
LKNDLLENL,CLASS-1,HLA-B39,B*3901,HUMAN,VIRAL,P26147,Uniprot,ARCHIVES OF VIROLOGY 2002 147 1933-1942
LLADARVCSC,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
LLALLSCLTI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P27958,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
LLALLSCLTV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P27954; P27959; P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742; JOURNAL OF VIROLOGY 1995 69 2462-2470; HEPATOLOGY 2001 33 1533-1543; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123
LLAPGAKQNV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
LLAQFTSAI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
LLCLIFLLV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P31873,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
LLCPAGHAV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 95 521-530; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230
LLCPTGHAV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27958,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
LLDDEAGPL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P17394,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
LLDFVRFMGV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF VIROLOGY 1996 70 8858-8864
LLDGTATLRL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6; PROC.NATL.ACAD.SCI. USA 1994 91 6458-6462
LLDYQGMLPV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P17399; P31873,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
LLFGAPVYV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03409,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
LLFGYPVYV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0205; A*0201,HUMAN,VIRAL,P03409,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 685-693; JOURNAL OF IMMUNOLOGY 1992 149 214-221; PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
LLFLLLADA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27960,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
LLFNILGGWV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26664; P26663,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101; JOURNAL OF CLINICAL INVESTIGATION 1997 100 2376-2385; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123
LLGATCMFV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P24385,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1998 28 193-200
LLGLWGLTGL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,not applicable,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
LLGPADGMVSK,CLASS-1,Patr-A*0101,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 2001 15 883-895
LLGPGRPYR,CLASS-1,HLA-A31; HLA-A33; HLA-A31; HLA-A33,A*31012; A*3301,HUMAN,CANCER; SELF PEPTIDE,P40126,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 2207-2216; CORNEA 2000 19 S2-S6
LLGRDSFEV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
LLGRNSFEV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE; HUMAN,P04637,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841; HUMAN IMMUNOLOGY 2001 62 791-798
LLGRNSSFEV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04637,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997
LLKEKGGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P18801,Uniprot,PROC.NATL.ACAD.SCI. USA 1997 94 1890-1895
LLLCLIFLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P30019,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534
LLLEAGALV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
LLLEAVPAV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 2000 60 6448-6456
LLLIALWNL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03230http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2003 101 3150-3156
LLLLTVLTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
LLLTVLTVV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
LLMDCSGSI,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P16893,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
LLMGTLGIV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2281-2289
LLPENNVLSPL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04637,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 2072-2077; PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997
LLPIFFCLWV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P17397,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
LLPRELFPPL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P78395,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
LLPRRGPRL,CLASS-1; n/a,HLA-A2; HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; LIVER 1996 16 174-182; JOURNAL OF MEDICAL VIROLOGY 2002 66 472-480
LLQDWHVIL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
LLREEVSFRV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,HEPATOLOGY 2001 33 1533-1543
LLSAWILTA,CLASS-1,HLA-A2,A*0203,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 573-582
LLSLLLLMPV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16790,Uniprot,CANCER RESEARCH 1999 59 5554-5559
LLSSNLSWL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
LLVDLLWLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03230http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2003 101 3150-3156
LLVPFVQWFV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P24025,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
LLVVMGTLV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
LLWAARPRL,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF VIROLOGY 1998 72 6614-6620
LLWKGEGAV,CLASS-1,HLA-A1,A*0201,HUMAN,VIRAL,P12502,Uniprot,VACCINE 2001 19 4121-4129
LLWTLVVLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 3325-3334
LMALTLSPYYKRY,CLASS-1,HLA-A29,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3339-3344
LMAQEALAFL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 82 442-448
LMAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LMGYIPLVGA,CLASS-1,H-2d; H-2d,H-2Dd,MOUSE,VIRAL,P27954; P27959,Uniprot,JOURNAL OF VIROLOGY 1994 68 3334-3342; JOURNAL OF INFECTIOUS DISEASES 1996 173 24-31
LMIIPLINV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
LMVLMLAAL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
LMWAKIGPV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P20916,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 10859-10863
LPAVVGASPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LPAVVGLSAGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LPAVVGLSPGEQE,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LPAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LPAVVGLSPGEQEY,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LPCRIKQFINMWQEVGKAMY,CLASS-1,HLA-A2,,HUMAN,VIRAL,P19551,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
LPCRIKQII,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P19551,Uniprot,HUMAN IMMUNOLOGY 1999 60 177-186
LPGCSFSIF,CLASS-1,HLA-B7; HLA-A24,,HUMAN,VIRAL,P27954,Uniprot,VIROLOGY 1999 257 177-190; AIDS 1998 12 2073-2074
LPKLPGVPF,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P26663; Q00269,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744; VIROLOGY 1998 251 132-140
LPPLERLTLD,CLASS-1,HLA-B56,,HUMAN,VIRAL,P05866,Uniprot,VACCINE 2001 19 4385-4395
LPPVVAKEI,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P03368,Uniprot,HUMAN IMMUNOLOGY 1999 60 177-186
LPRWPPPQL,CLASS-1,HLA-B7,,HUMAN,SYNTHETIC,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1999 190 1793-1799
LPSDFFPSV,CLASS-1,HLA-B51,,HUMAN,VIRAL,Q05495,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
LPYLAWLVF,CLASS-1,H-2d,H-2Ld,MOUSE,CANCER,P19473,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
LPYLGWLVF,CLASS-1,H-2d; H-2d; H-2d,H-2Ld,MOUSE,CANCER,P19473,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2283-2288; EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745; INTERNATIONAL IMMUNOLOGY 2001 13 625-632
LQDIEITCV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06463,Uniprot,VIRUS RESEARCH 1998 54 23-29
LQNAASIA,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
LQNAASIAGL,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
LQTTIHDII,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03126,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
LRGKWQRRYR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1993 178 879-887
LRKPKHKKL,CLASS-1,HLA-B8,,HUMAN,PARASITE,P13814,Uniprot,LANCET 1995 345 8956 1003-1007
LRPPSFLRAPSWIDTG,CLASS-1,H-2g,H-2Ag,MOUSE,SELF PEPTIDE,P23927,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 104 47-57
LRRYLENGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30464,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
LRRYLKNGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30503,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
LRSRYWAI,CLASS-1,HLA-B27,B*2702,HUMAN,VIRAL,P26065,Uniprot,IMMUNITY 1995 3 65-77
LRYWAIRTR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03467,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
LSAFPFDL,CLASS-1,H-2d; H-2d; H-2b,H-2Ld; H-2Kb,MOUSE,HUMAN; SELF PEPTIDE,Q02218; Q60597,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 11990-11992; JOURNAL OF IMMUNOLOGY 1998 160 77-86
LSPFPFDL,CLASS-1,H-2d; H-2d; H-2b; H-2d; H-2d; H-2d,H-2Ld; H-2Kb,MOUSE,HUMAN; SELF PEPTIDE,Q02218; Q60597,Uniprot,SEMIN.IMMUNOLOGY 1993 5 81-94; JOURNAL OF IMMUNOLOGY 1998 160 77-86; MOLECULAR IMMUNOLOGY 1997 34 273-281; JOURNAL OF IMMUNOLOGY 2001 166 3028-3034; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2001 289 825-831
LSPFPFDLL,CLASS-1,H-2d,H-2Ld,MOUSE,HUMAN,Q02218,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 11487-11491
LSPRTLNAW,CLASS-1,Mamu-A*01,,CHIMPANZEE,VIRAL,P05894,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
LSPYPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,HUMAN,Q02218,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 4495-4502
LSTNLPYGK,CLASS-1,HLA-A11,,HUMAN,PARASITE,P16893,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
LSVKYGVSVQDI,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
LTFNYRNL,CLASS-1,H-2b,H-2Kb,MOUSE,SELF PEPTIDE,O77968,Uniprot,JOURNAL OF IMMUNOLOGY 2002 168 3131-3134
LTKAILGFVFTLTVPSERG,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
LTKGILAFVFTLTVPSERG,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
LTKGILGFVFKLTVPSERG,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
LTKGILGFVFTLTVPSERG,CLASS-1; CLASS-2,HLA-A2; HLA-DR4,A*0201; DRB1*0401,HUMAN,VIRAL,P03487; P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947; JOURNAL OF VIROLOGY 2000 74 8740-8743
LTKGISGFVFTLTVPSERG,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
LTKSILGFVFTLTVPSERG,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1989 143 2939-2947
LTVILGVLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
LURCNCQK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03126,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
LVGPTPVNI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P20892,Uniprot,JOURNAL OF VIROLOGY 2001 75 1301-1311
LVMAQLLRI,CLASS-1,HLA-A2; HLA-A2,,HUMAN,VIRAL,P27953,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; JOURNAL OF MEDICAL VIROLOGY 2002 66 472-480
LVNLLIFHINGKIIK,CLASS-1,HLA,,HUMAN,PARASITE,not applicable,Uniprot,PARASITE IMMUNOLOGY 2000 22 469-473
LVSEEIVTEEG,CLASS-1,H-2k/d,,MOUSE,PARASITE,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 379-389
LVVLGLLAV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P19440,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
LWAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
LWVTVYYGVPVWKEATTTLFCA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P04580,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
LYGVSFSEL,CLASS-1,H2-d,H2-Kd,HUMAN,VIRAL,P03114,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2001 254 59-66
LYSACFWWL,CLASS-1,HLA-A2,A*2402,HUMAN,SELF PEPTIDE,P51810,Uniprot,JOURNAL OF IMMUNOLOGY 2003 170 1579-1585
LYSDPADYF,CLASS-1,HLA-A24,A*0201,HUMAN,SELF PEPTIDE,Q9Y3Q0,Uniprot,CLINICAL CANCER RESEARCH 2002 8 3885-3892
LYVDSLFFL,CLASS-1,HLA-A24; HLA-A24,,HUMAN,CANCER,P78395,Uniprot,IMMUNITY 1997 6 199-208; CORNEA 2000 19 S2-S6
MAYSESQLIAKF,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
MDIAIHHPWIRRPFFP,CLASS-1,H-2g,H-2Ag,MOUSE,SELF PEPTIDE,P23927,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 104 47-57
MEKLKELEK,CLASS-1,HLA-B8,,HUMAN,MISCELLANEOUS,Q58241,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
MEVDPIGHLY,CLASS-1,HLA-B44; HLA-B44; HLA-B44; HLA-B35; HLA-B44; HLA-B18,B*4402; B*4403; B*3501; B*1801,HUMAN,CANCER,P43357,Uniprot,IMMUNOGENETICS 1996 43 377-383; TISSUE ANTIGENS 1999 53 111-121; TISSUE ANTIGENS 2001 57 103-109; CORNEA 2000 19 S2-S6; TISSUE ANTIGENS 2002 60 16-24
MFFINALTLLVP,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03889,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1991 9 351-372
MFFINALTLLVPILIAM,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03889,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1991 9 351-372
MFFINILTLLVP,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03889,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1991 9 351-372
MFFINILTLLVPILIAM,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03889,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1991 9 351-372
MFINRWLFS,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03921,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3301-3307
MGGMNRRPI,CLASS-1,H-2b,H-2Db,MOUSE,CANCER,P02340,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 239-246
MGLIYNRM,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
MGLKFRQL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03146,Uniprot,VACCINE 2000 18 2878-2885
MGPFNIDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
MINAYLDKL,CLASS-1,HLA-A2,A*0202,HUMAN,MISCELLANEOUS,not applicable,Uniprot,LANCET 1995 345 8956 1003-1007
MLDLQPETT,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
MLGTHTMEV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802; CORNEA 2000 19 S2-S6
MLLAVLYCL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P14679,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 759-764; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; JOURNAL OF IMMUNOTHERAPY 2001 24 212-220; CORNEA 2000 19 S2-S6
MLLSVPLLL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P27797,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427; JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
MLMAQEALAFL,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,not applicable,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 82 442-448
MLNIPSINV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P06725; P18139http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518; BLOOD 2001 98 1872-1881
MLPLECQYL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDESELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
MMRKLAILSV,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P13814,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3922-3931
MMWYWGPSL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P24025,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534
MNIFTTSIL,CLASS-1b,H2-M3,,MOUSE,SELF PEPTIDE,P03921,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3301-3307
MPGRAFVTI,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,VIRAL,P04582,Uniprot,JOURNAL OF VIROLOGY 1996 70 3252-3257; JOURNAL OF IMMUNOLOGY 1994 152 5603-5612
MPKVHIEF,CLASS-1,HLA-B8,B*0802,HUMAN,CANCER,P43357,Uniprot,IMMUNOGENETICS 1998 48 56-61
MPNDPNRNV,CLASS-1,HLA-B7; HLA-B35,,HUMAN,PARASITE,P05691,Uniprot,LANCET 1995 345 8956 1003-1007
MPVGGQSSF,CLASS-1,HLA-B35,B*3501,HUMAN,BACTERIAL,P12942,Uniprot,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
MSIINFEKL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,P01012,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 585-598
MSLQRQFLR,CLASS-1,HLA-A31; HLA-A31; HLA-A31,A*31012,HUMAN,CANCER; SELF PEPTIDE,not applicable; P40126,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1131-1140; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
MSTNPKPQKKNKR,CLASS-1,HLA-A11,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF VIROLOGY 1993 67 7522-7532
MSYSWTGALVTPCAAE,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P26664,Uniprot,JOURNAL OF VIROLOGY 1992 66 4098-4106
MSYSWTGALVTPCAEE,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P26664,Uniprot,JOURNAL OF VIROLOGY 1994 68 3334-3342
MTQGQHFLQKV,CLASS-1,HLA-B13,B*1302,HUMAN,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1617-1623
MVKISGGPR,CLASS-1,HLA-A34,A*3402,HUMAN,CANCER,P43360,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1999 29 602-607
MVWFNMDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
MWAQDAAAMF,CLASS-1,HLA-B44,B*4403,HUMAN,BACTERIAL,Q11031,Uniprot,AMERICAN JOURNAL OF CRITICAL CARE MEDICINE 2002 166 843-848
MWSGTFPINAY,CLASS-1,Patr-A*0601; Patr-A*0601,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 1999 10 439-449; IMMUNITY 2001 15 883-895
MYAPPIGGQI,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03383,Uniprot,IMMUNOLOGY LETTERS 1995 46 199-205
NAACMALNI,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P17451,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6855-6866
NAHEGQLVI,CLASS-1,HLA-B51,,HUMAN,VIRAL,P05133,Uniprot,JOURNAL OF VIROLOGY 1999 73 5301-5308
NANPDCKTI,CLASS-1,HLA-B51; HLA-B51,B*5101,HUMAN,VIRAL,P04594; P05888,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985; HUMAN IMMUNOLOGY 1999 60 177-186
NANPNVDP,CLASS-1,HLA,,HUMAN,PARASITE,P05691,Uniprot,PARASSITOLOGIA 1999 41 397-402
NAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
NASRCWVAM,CLASS-1,HLA-B35,,HUMAN,VIRAL,P27957,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3339-3344
NCSFNISTSI,CLASS-1,HLA-Cw8,,HUMAN,VIRAL,P03377,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
NDDSYIPSAEKI,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P23093,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
NEDSYVPSAEQI,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P06914,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
NEGCGWAGW,CLASS-1,HLA-B44,B*4403,HUMAN,VIRAL,P26663,Uniprot,TISSUE ANTIGENS 1997 49 526-528
NEGLGWAGW,CLASS-1,HLA-B44; HLA-B44,,HUMAN,VIRAL,P26663; P27959,Uniprot,HEPATOLOGY 1993 18 1039-1044; JOURNAL OF GASTROENTEROLOGY 1995 30 809-812
NEKYAQAYPNVS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
NFESTGNLIAPE,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P03451,Uniprot,NATURE 1989 342 6246 180-182
NGLWNLDLI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
NLGATLKGV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P19544,Uniprot,IMMUNOGENETICS 2000 51 99-107
NLGKVIDTL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
NLGNLNVSI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
NLKLKLHSF,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,Q09028,Uniprot,IMMUNOGENETICS 1998 48 56-61
NLKLKLHTF,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,Q16576,Uniprot,IMMUNOGENETICS 1998 48 56-61
NLLKVNIHI,CLASS-1,HLA-A2,,HUMAN,n/a,not applicable,Uniprot,BRITISH JOURNAL OF CANCER 2002 87 1006-1012
NLPGCSFSI,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
NLQSLTNLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P17394,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
NLSWLSLDV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
NLTISDVSV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
NLVPMVATV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P06725; P18139,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539; BLOOD 2001 98 1872-1881; HUMAN IMMUNOLOGY 2003 64 440-452
NLVPMVATVQ,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06725,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
NLYVSLLLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
NMFTPYIGV,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P17451,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6855-6866
NMVPFFPPV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
NNLDNLRDYI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 1994 39 467-479
NPDIVIYQY,CLASS-1,HLA-B35; HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P03369,Uniprot,AIDS 1996 10 1075-1083; JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
NPKASLLSL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P26589,Uniprot,JOURNAL OF VIROLOGY 2000 74 7694-7697
NPVPVGNIY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P17756,Uniprot,NATIONAL MEDICINE 1995 1 59-64
NQTDETLSNV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
NSCMGLIY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03488,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 335-339
NSSASAIIAEAQ,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
NSSKVSQNY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P12494,Uniprot,NATIONAL MEDICINE 1995 1 59-64
NTFRHSVVV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P04637,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
NVDLHAKLHPTKGET,CLASS-1,H-2d,,MOUSE,NEMATODE,P29030,Uniprot,VACCINE 2002 20 3685-3694
NVLHFFNAPL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P14866,Uniprot,CANCER RESEARCH 2001 61 2038-2046
NVSEVVEEK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
NYARTEDFF,CLASS-1,HLA-A24,A*0201,HUMAN,SELF PEPTIDE,Q9Y3Q0,Uniprot,CLINICAL CANCER RESEARCH 2002 8 3885-3892
NYDNAGTNL,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P04923,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 4134-4141
NYKHCFDEI,CLASS-1,HLA-A24,,HUMAN,CANCER,P43355,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 80 169-172
NYKHCFPEI,CLASS-1,HLA-A24,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2928-2936
NYMCNSSCM,CLASS-1,HLA-A24,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
PAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
PAPGSTAP,CLASS-1,H-2b,H-2Db,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
PASIINFEKLGT,CLASS-1,H2-b,H2-Kb,MOUSE,CHICKEN,P01012,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 4157-4162
PAVVGLSPGEQEA,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
PCVLWPVLPEPLPQGQLTAYHVS,CLASS-1,HLA,,HUMAN,VIRAL,P03206,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
PDTRPAPGS,CLASS-1,H-2k,H-2Kk,MOUSE,CANCER,P15941,Uniprot,VACCINE 2000 18 2059-2071
PEIVTHS,CLASS-1,HLA-A2,,HUMAN,VIRAL,P35961,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
PIQKETWETW,CLASS-1,HLA-A32,,HUMAN,VIRAL,P20875,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 2616-2623
PKSDNQIKAVPAS,CLASS-1,H-2k,,MOUSE,VIRAL,P12589,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 3877-3882
PLDGEYFTL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P04637,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2216-2225; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
PLEEELPRL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
PLFQVPEPV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P02771,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 5300-5308
PLKQHFQIV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06464,Uniprot,IMMUNOLOGY 1994 81 222-227
PLLYRLGAV,CLASS-1; n/a,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; LIVER 1996 16 174-182
PLPIHTAEL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
PLRPMTYK,CLASS-1,HLA-A1,A*0101,HUMAN,VIRAL,P19545,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
PLTFGWCYKL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221
PNCGGEFFY,CLASS-1,HLA-A29,,HUMAN,VIRAL,P12491,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
PPIPVGDIY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P04594,Uniprot,NATIONAL MEDICINE 1995 1 59-64
PPSGKGGNY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P24106,Uniprot,NATIONAL MEDICINE 1995 1 59-64
PQASGVYM,CLASS-1,H-2d,,MOUSE,VIRAL,P07400,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 768-778
PRKGYKDGNEYI,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
PSNENMETM,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P26065,Uniprot,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
PTEAAKPAPAPS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
PVDEEIVQEEG,CLASS-1,H-2k,,MOUSE,PARASITE,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 379-389
QAEPDRAHY,CLASS-1,HLA-B18; HLA-B18,,HUMAN,VIRAL,P03129,Uniprot,IMMUNOLOGY 1991 72 3-9; EURO.JOURNAL OF IMMUNOLOGY 2000 30 2281-2289
QAFPQCTIL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03362,Uniprot,VIROLOGY 1996 226 102-112
QAFPQCTILQY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03362,Uniprot,VIROLOGY 1996 226 102-112
QAGIGILLA,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P28636,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
QAHRALDLVA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2895-2902
QAKGKELNEF,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,Q9UHV9,Uniprot,IMMUNOGENETICS 1998 48 56-61
QAKWRLQTL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF GENERAL VIROLOGY 1994 75 2489-2493
QAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
QASPFPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QASQEVKNW,CLASS-1,HLA-Cw4,Cw*0401,HUMAN,VIRAL,P05887,Uniprot,IMMUNOLOGY LETTERS 1997 55 145-149
QASQEVKNWM,CLASS-1,HLA-Cw4,Cw*0401,HUMAN,VIRAL,P05887,Uniprot,IMMUNOLOGY LETTERS 1997 55 145-149
QASQEVKNWMTET,CLASS-1,HLA-Cw4,Cw*0401,HUMAN,VIRAL,P05887,Uniprot,IMMUNOLOGY LETTERS 1997 55 145-149
QAVANGGAI,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,Q9RB65,Uniprot,INFECTION AND IMMUNITY 2002 70 3336-3343
QEFAGCKKIFG,CLASS-1,H2-d,H2-Ed,MOUSE,CANCER,Q60553,Uniprot,PEPTIDES 2003 24 193-197
QEFFWDANDIYRIFA,CLASS-1,HLA-A1,,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
QFKQKALGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF VIRAL HEPATITIS 2002 9 18-28
QGINNLDNL,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; JOURNAL OF VIROLOGY 1990 64 1192-1200
QGQYMNTPW,CLASS-1,Mamu-B*04,,RHESUS,VIRAL,P31818,Uniprot,NATURE MEDICINE 1999 5 1270-1276
QIISFFSPL,CLASS-1,H2-b,H2-Kb,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
QILKGLLFL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
QIYQEPFKNLK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P03368,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
QLAPFPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLFEDNYAL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
QLFTFSPRR,CLASS-1,HLA-A3; HLA-A3,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689; HUMAN IMMUNOLOGY 2003 64 497-504
QLIAKFGTAFKA,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
QLIPCMDVVL,CLASS-1,HLA-A2,A*0201,HUMAN,ALLERGEN,P04721,Uniprot,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
QLMPYGCLL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2109-2117
QLRRHIDLIV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,HUMAN IMMUNOLOGY 2003 64 224-230
QLRRHIDLLV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26664; P27954,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; HUMAN IMMUNOLOGY 2003 64 497-504
QLSAFPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSLLMWIT,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A1; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P78358,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 265-270; JOURNAL OF IMMUNOTHERAPY 2001 24 1-9; CORNEA 2000 19 S2-S6
QLSPAPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSPFAFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSPFPADL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSPFPFAL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSPFPFDA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLSPFPFDL,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 11487-11491; JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
QLTPHTKAV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
QMTSQLECM,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,P50902http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2000 95 286-293
QNARALDLVA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2895-2902
QNGALAINTF,CLASS-1,HLA-B15; HLA-B62,B*1501,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF VIROLOGY 1996 70 8858-8864
QNHRALDLAA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2895-2902
QNHRALDLVA,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,INTERNATIONAL IMMUNOLOGY 2001 13 625-632
QNHRALDLVI,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,P14685,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 2895-2902
QNILLSNAPLGPQFP,CLASS-2; CLASS-1,HLA-DR4; HLA-DR4,DRB1*0401,HUMAN,CANCER; SELF PEPTIDE,P14679,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1965-1971; CORNEA 2000 19 S2-S6
QNPIPVGNI,CLASS-1,Mamu-A*01,,CHIMPANZEE,VIRAL,P05894,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
QPETTDLYCY,CLASS-1,HLA-B18,,HUMAN,VIRAL,P03129,Uniprot,IMMUNOLOGY 1991 72 3-9
QPQNGQFIHFY,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P09992,Uniprot,JOURNAL OF VIROLOGY 1992 66 6755-6762
QPRAPIRPI,CLASS-1,HLA-B7,B*0702,HUMAN,VIRAL,P03204,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2221-2228
QQLCVYWTV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9Y6K5,Uniprot,CANCER RESEARCH 2001 61 2038-2046
QRFCRMPL,CLASS-1,H-2k,H-2Dk,MOUSE,VIRAL,P03076,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1724-1734
QRGPGRAFV,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P04624,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 1973-1986
QRGPGRAFVTI,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P04624,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 1973-1986
QRGPGRAFVTIG,CLASS-1,H-2d; H-2d,H-2Ld; H-2Dd,MOUSE,VIRAL,P04582; P04624,Uniprot,PROC.NATL.ACAD.SCI. USA 1988 85 3105-3109
QRPYGYDQIM,CLASS-1,HLA-B7,,HUMAN,SELF PEPTIDE,Q15532,Uniprot,CANCER RESEARCH 2001 61 6868-6875
QTFLATCINGVCWTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,HEPATOLOGY 2003 37 577-589
QTNFKSLLR,CLASS-1; CLASS-2,HLA; HLA-A11,,HUMAN,PARASITE,not applicable,Uniprot,PARASITE IMMUNOLOGY 2000 22 469-473; JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
QTTQATTPAPKV,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
QVHPQKVTK,CLASS-1,HLA-A3,,HUMAN,CANCER,P07288,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 3186-3194
QVMSLHNLV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
QVPKFHLPV,CLASS-1,Mamu-A*01,,CHIMPANZEE,VIRAL,P05897,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
QVPLRPMTYK,CLASS-1,HLA-A11; HLA-B35; HLA-B27; HLA-A3; HLA-A3,A*1101; B*3501; A*0301,HUMAN,VIRAL,P24741; P03404,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 728-732; JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
QVRDQAEHLK,CLASS-1,HLA-B58,,HUMAN,VIRAL,P17283,Uniprot,VACCINE 2001 19 4385-4395
QVSQNYPIV,CLASS-1,HLA-A68; HLA-B18,A*6802,HUMAN,VIRAL,P18800,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1758-1765
QWISSECTTPC,CLASS-1,Patr-A*0901,,CHIMPANZEE,VIRAL,P27958,Uniprot,IMMUNITY 2001 15 883-895
QYDPVAALF,CLASS-1,HLA-A24; HLA-A24; HLA-A24,A*2402,HUMAN,VIRAL; SELF PEPTIDE,P06725; P18139,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377; IMMUNOLOGY LETTERS 2002 83 21-30; BLOOD 2001 98 1872-1881
QYNKTGYFI,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q9ZD54,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
QYSWFVNGTF,CLASS-1,HLA-A24,,HUMAN,CANCER,P06731,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
QYVKVYLESF,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
RAHYNIVTF,CLASS-1,H-2b; H2-d,H-2Db; H2-Kd,MOUSE; HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 2242-2249; JOURNAL OF IMMUNOLOGICAL METHODS 2001 254 59-66
RAIEAQQHL,CLASS-1,HLA-B51,,HUMAN,VIRAL,P04579,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
RAIEAQQHLL,CLASS-1,HLA-B51,,HUMAN,VIRAL,P35961,Uniprot,VACCINE 2001 19 4385-4395
RAKFKQLL,CLASS-1,HLA-B8; HLA-B8,,HUMAN,VIRAL,P03206,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617
RAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
RAPGRAFVTI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P04578,Uniprot,INTERNATIONAL IMMUNOLOGY 1996 8 641-649
RAYRAILHI,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P19551,Uniprot,HUMAN IMMUNOLOGY 1999 60 177-186
RAYVYQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RCDLEDRDRSELSL,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P26662,Uniprot,IMMUNITY 1999 10 439-449
RCDLEDRDRSELSPL,CLASS-1,Patr-A*0601,,CHIMPANZEE,VIRAL,P26662,Uniprot,IMMUNITY 2001 15 883-895
RCQIFANI,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P11225,Uniprot,JOURNAL OF VIROLOGY 1995 69 8127-8131
RDLDASREAKKQ,CLASS-1,H-2k,,MOUSE,VIRAL,P08089,Uniprot,INTERNATIONAL IMMUNOLOGY 1997 9 1723-1733
RDWAHNGL,CLASS-1,HLA-B37,,HUMAN,VIRAL,P26664,Uniprot,VIROLOGY 1998 251 132-140
REGNASPCWVAMTPTVATRD,CLASS-1,HLA-B35,,HUMAN,VIRAL,P27957,Uniprot,JOURNAL OF IMMUNOLOGY 1992 149 3339-3344
REHSGNEI,CLASS-1,HLA-Kk,,MOUSE,VIRAL,P05769,Uniprot,VIRAL IMMUNOLOGY 2001 14 135-149
REISVPAEIL,CLASS-1,HLA-B60,,HUMAN,VIRAL,Q00269,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
RELPRFMNYT,CLASS-1,HLA-A1,A*0101,HUMAN,VIRAL,P03420,Uniprot,IMMUNOLOGY 2003 108 474-480
REPHNEWTL,CLASS-1,HLA-B40,B*4002,HUMAN,VIRAL,P05926,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
REPVTKAEML,CLASS-1,HLA-B37,B*3701,HUMAN,CANCER,P43356,Uniprot,CANCER RESEARCH 1999 59 2668-2674
RFKMFPEVK,CLASS-1,HLA-A11,A*1101,HUMAN,SELF PEPTIDE,Q05329,Uniprot,HUMAN IMMUNOLOGY 1999 60 652-664
RGEVYQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGFYVQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGILGFVFTLTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 2045-2057
RGPGRAFTVTI,CLASS-1,H-2d; H-2d,H-2Dd,MOUSE,VIRAL,P04582,Uniprot,VACCINE 1999 17 589-596; IMMUNOLOGY LETTERS 1999 66 177-181
RGPGRAFVTI,CLASS-1,H-2d; HLA-A2; H-2d; H-2d; HLA-A2; H-2d; H-2d; H-2d; H-2d; HLA-A1; H-2d,H-2Dd; A*0201; H-2Ld,MOUSE; HUMAN,VIRAL,P04578; Q9PXE1; P04582,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1993 178 1877-1892; PROC.NATL.ACAD.SCI. USA 1988 85 3105-3109; IMMUNOLOGY 2000 101 76-82; MOLECULAR IMMUNOLOGY 1997 34 273-281; VACCINE 2001 19 4121-4129; JOURNAL OF GENERAL VIROLOGY 1998 79 83-90
RGSRPSWGPNDPRRRSRNLG,CLASS-1,HLA-A2/A30/B41/B15,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
RGYAYQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYRYQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVPQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVWQGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYEGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYGGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYGHL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYNGL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYQGF,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYQGL,CLASS-1,H-2b; H-2b; H-2b; H-2b; H-2b,H-2Kb,MOUSE,VIRAL; CHICKEN,P11210; P11212,Uniprot,NATURE 1990 348 6298 213-216; NATURE IMMUNOLOGY 2000 1 145-150; JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155; IMMUNITY 2001 14 231-242; JOURNAL OF IMMUNOLOGY 2001 167 4869-4877
RGYVYQGT,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYQGY,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYQHL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RGYVYQYL,CLASS-1,H-2b,H-2Kb,MOUSE,SYNTHETIC,P11212,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
RIAECILGM,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 455-462
RIETRSARH,CLASS-1,HLA-A3,,HUMAN,VIRAL,P07566,Uniprot,VIROLOGY 1997 235 286-292
RIIYDRKFL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
RIKQIINMW,CLASS-1,HLA-A32,,HUMAN,VIRAL,P19551,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 2616-2623
RILGAVAKV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P18206,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2509-2516
RILQQLLFI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05954,Uniprot,JOURNAL OF VIROLOGY 2001 75 1301-1311
RIQRGPGRAFVTI,CLASS-2; CLASS-1,I-Ad; H-2d,,MOUSE,VIRAL,P04582; Q9PXE1,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 1973-1986; JOURNAL OF VIROLOGY 2000 74 5769-5775
RIQRGPGRAFVTIGK,CLASS-2; CLASS-1,I-Ad; H-2d; H-2d,H-2Dd,MOUSE; HUMAN,VIRAL,P04582,Uniprot,MOLECULAR IMMUNOLOGY 1994 31 1-19; IMMUNOLOGY 2000 101 76-82; EURO.JOURNAL OF IMMUNOLOGY 1993 23 2777-2781
RIQRGRGRAFVTIGK,CLASS-1,HLA-A2,,HUMAN,VIRAL,P04582,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
RIRTWKSLVK,CLASS-1,HLA-A3,A*0301,HUMAN,VIRAL,P03402,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 2743-2752
RKLKREITF,CLASS-1,"Saoe-G, unassigned; Saoe-G*12; Saoe-G*02; Saoe-G*04",,TAMARIN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1374-1382
RKLKREITH,CLASS-1,Saoe-G*06; Saoe-G*04,,TAMARIN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1374-1382
RKTPRVTGGGAMAGA,CLASS-1,HLA-B7,,HUMAN,VIRAL,P18139,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
RLEDVFAGK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P21429,Uniprot,JOURNAL OF IMMUNOTHERAPY 2003 26 41-46
RLGATIWQL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03230http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2003 101 3150-3156
RLGPTLMCL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 2000 60 6448-6456
RLGVRATRK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P27959,Uniprot,HUMAN IMMUNOLOGY 2003 64 497-504
RLLGSLNST,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
RLLQETELV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208; JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
RLMKQDFSV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6985-6992; CORNEA 2000 19 S2-S6; JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
RLNMFTPYI,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P17451,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6855-6866
RLPRIFCSC,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 6985-6992; CORNEA 2000 19 S2-S6
RLQEWCSVI,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,CANCER RESEARCH 2001 61 2038-2046
RLRAEAQVK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2221-2228
RLRDLLLIVTR,CLASS-1,HLA-A3; HLA-A31,A*0301; A*31012,HUMAN,VIRAL,P04578; P35961,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 179 463-472
RLRPGGKKK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P05889,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1423-1433
RLSFQLMRPPNMTP,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P04509,Uniprot,VACCINE 2003 21 761-767
RLTRFLRSV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P24385,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1998 28 193-200
RLVTLKDIV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P04020,Uniprot,IMMUNOLOGY 1994 81 222-227
RLWHYPCTV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27960,Uniprot,JOURNAL OF HEPATOLOGY 2001 34 321-329
RLYVGGPMHNSKGDLCGYRR,n/a; CLASS-1,HLA-A1/A30/B35,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
RMFPNAPYL,CLASS-1,HLA-A2; H-2b,A*0201; H-2Db,HUMAN; MOUSE,CANCER,P19544; P22561,Uniprot,IMMUNOGENETICS 2000 51 99-107
RMPEAAPPV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; HUMAN; SELF PEPTIDE,P04637,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1993 23 2072-2077; PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997; HUMAN IMMUNOLOGY 2001 62 791-798; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841
RMYSPTSI,CLASS-1,HLA-B52,,HUMAN,VIRAL,P05889,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
RMYVGGVEHR,CLASS-1,HLA-A3; HLA-A3,,HUMAN,VIRAL,P27960,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689; HUMAN IMMUNOLOGY 2003 64 497-504
RPAPGSTAP,CLASS-1,H-2b,H-2Db,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
RPHERNGFTV,CLASS-1,HLA-B7,,HUMAN,VIRAL,P18139http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2001 98 1872-1881
RPHERNGFTVL,CLASS-1,HLA-B7,B*0702,HUMAN,VIRAL,P18139,Uniprot,HUMAN IMMUNOLOGY 2003 64 440-452
RPIIKPATL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P13884,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 303-308
RPIVSTQLL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03383,Uniprot,AIDS 1996 10 1075-1083
RPLTDFDQGW,CLASS-1,HLA-B53,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
RPMTYKAAV,CLASS-1,HLA-B7,,HUMAN,VIRAL,P03404,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
RPQASGVYM,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,VIRAL,P09992,Uniprot,JOURNAL OF VIROLOGY 1989 63 4303-4310; MOLECULAR IMMUNOLOGY 1997 34 273-281
RPQASGVYMGNLTAQ,CLASS-1,H-2d; H-2d; H-2d,H-2Dd,MOUSE,VIRAL,P07400,Uniprot,JOURNAL OF VIROLOGY 2000 74 5769-5775; INFECTION AND IMMUNITY 2000 68 3867-3872; FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 1999 26 167-173
RPQVPLRPMTY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03405,Uniprot,AIDS 1996 10 1075-1083
RPVVSTQLLL,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12491,Uniprot,VACCINE 2001 19 4385-4395
RQIKNFHEL,CLASS-1,H2-b,H2-Db,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
RRARSLSAERY,CLASS-1,HLA-B27; HLA-B27; HLA-B27,B*2702; B*2705,HUMAN,VIRAL,P12977; P03203,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431; JOURNAL OF IMMUNOLOGY 1998 161 5252-5259
RRFFPYFV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFFPYHV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFFPYLV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFFPYWV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFFPYYV,CLASS-1,HLA-B27; HLA-B27; HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 5481-5490; JOURNAL OF IMMUNOLOGY 2000 164 329-337; JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFLPYYV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFWPYYV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRFYPYYV,CLASS-1,HLA-B27,B*2705,HUMAN,SELF PEPTIDE,P20618,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
RRIYDLIEL,CLASS-1,HLA-B27; HLA-B27; HLA-B27; HLA-B27; HLA-B27,B*2702; B*2705; B*2704,HUMAN,VIRAL,P12977; P03204,Uniprot,JOURNAL OF VIROLOGY 2000 74 1801-1809; JOURNAL OF IMMUNOLOGY 1998 161 5252-5259
RRKAMFEDI,CLASS-1,HLA-B27,B*2705,HUMAN,BACTERIAL,Q9ZFE0,Uniprot,INFECTION AND IMMUNITY 1991 59 79-90
RRLGRTLLL,CLASS-1,H-2k; H-2k,H-2Dk,MOUSE,VIRAL,P03076,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1724-1734; JOURNAL OF IMMUNOLOGY 1999 162 3933-3941
RRQDILDLWI,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P04601,Uniprot,AIDS 1997 11 536-538
RRRWRRLTV,CLASS-1,HLA-B27,B*2702,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1993 178 879-887
RRWIQLGLQK,CLASS-1,HLA-B27; HLA-B27,B*2705; B*2703,HUMAN,VIRAL,P15832,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
RRYLENGKETL,CLASS-1,HLA-B17,,HUMAN,SELF PEPTIDE,P10316,Uniprot,TISSUE ANTIGENS 1997 49 580-587
RRYLENGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30468,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
RRYLKNGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30503,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
RRYPDAVYL,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P35973,Uniprot,JOURNAL OF PEPTIDE RESISTANCE 1999 54 436-443
RSDSGQQARY,CLASS-1,HLA-A1,,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 323-333
RTFSFQLI,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P08275,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
RTLYQNVGTHVSVGTSTLNK,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03451,Uniprot,IMMUNOLOGY AND CELL BIOLOGY 1996 74 394-400
RTLYQNVGTYVSVGTSTLNK,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03451,Uniprot,PROC.NATL.ACAD.SCI. USA 1989 86 277-281
RVCEKMALY,CLASS-1,HLA-A3; HLA-A3; HLA-A3; HLA-A3,,HUMAN,VIRAL,P27958; P26663; P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; CELLULAR IMMUNOLOGY 2000 203 111-123
RVKEKYQHL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P19551,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
RVLEDGVNYA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF MEDICAL VIROLOGY 1999 58 239-246
RVNENMQHM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
RVRFFFPSL,CLASS-1,HLA-B7,,HUMAN,CANCER,P43355,Uniprot,TISSUE ANTIGENS 2000 55 149-152
RWNEKYAQAYPN,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
RWPSCQKKF,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,P50902http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2000 95 286-293
RYLENGKETL,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P10316,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
RYLENGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P10320,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
RYLKDQQL,CLASS-1,HLA-B27,,HUMAN,VIRAL,P04578,Uniprot,IMMUNOLOGY INVEST. 1995 24 489-497
RYLKDQQLL,CLASS-1,HLA-A24; HLA-A24,,HUMAN,VIRAL,P04578; P19550,Uniprot,JOURNAL OF VIROLOGY 1992 66 3151-3154; HUMAN IMMUNOLOGY 2001 62 791-798
RYLKNGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30503,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
RYSIFFDY,CLASS-1,HLA-A24,,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF GENERAL VIROLOGY 1994 75 2489-2493
SAACAAA,CLASS-1,H-2k,,MOUSE,ALLERGEN,P49278,Uniprot,JOURNAL OF IMMUNOLOGY 2002 169 2430-2435
SAACAIHR,CLASS-1,H-2d,,MOUSE,ALLERGEN,P49278,Uniprot,JOURNAL OF IMMUNOLOGY 2002 169 2430-2435
SAEQNKNHI,CLASS-1,H2-b,H2-Db,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
SAFPTTINF,CLASS-1,HLA-Cw2,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2928-2936
SAINFEKL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667
SAINNYAQKL,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; JOURNAL OF VIROLOGY 1990 64 1192-1200
SAINNYAQKLCT,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,JOURNAL OF VIROLOGY 1992 66 440-447
SALQNAASIA,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,BACTERIAL,P35635; P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 451-458; EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
SALQNAASIAGL,CLASS-1,H-2b,H-2Db,MOUSE,BACTERIAL,P06806,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 3161-3169
SAPDTRAP,CLASS-1,H-2d,H-2Kd,MOUSE,CANCER,P15941,Uniprot,VACCINE 2000 18 2059-2071
SAPDTRPAP,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
SAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
SASAIIAEAQKH,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
SAYGEPRKL,CLASS-1,HLA-Cw16; HLA-Cw3; HLA-Cw16; HLA-Cw16; HLA-Cw16,Cw*1601,HUMAN,CANCER,P43355,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2134-2140; JOURNAL OF IMMUNOLOGY 1999 163 2928-2936; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
SDEEEAIVAYTL,CLASS-1,HLA-B18; HLA-B18,,HUMAN,VIRAL,P13202,Uniprot,JOURNAL OF IMMUNOLOGY 1993 151 3971-3980
SDFKTWLKA,CLASS-1,Patr-B*1601,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 2001 15 883-895
SDYEGRLI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P15664,Uniprot,JOURNAL OF VIROLOGY 1991 65 5401-5409
SEGRSWAQPGFAWPLYGNEG,CLASS-1,HLA-A11/A29/B44/B47,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
SEIWRDIDF,CLASS-1,HLA-B44; HLA-B44; HLA-B44; HLA-B44; HLA-B44; HLA-B44,B*4402; B*4403,HUMAN,CANCER; SELF PEPTIDE,P14679,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 224-230; TISSUE ANTIGENS 1999 53 111-121; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
SENDRLRLL,CLASS-1,HLA-B40,B*4002,HUMAN,VIRAL,P03206,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 1791-1800
SEPCAAA,CLASS-1,H-2k,,MOUSE,ALLERGEN,P49278,Uniprot,JOURNAL OF IMMUNOLOGY 2002 169 2430-2435
SEPCIIHR,CLASS-1,H-2d,,MOUSE,ALLERGEN,P49278,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 291-299
SESLKMIFGIDVKEVD,CLASS-1,HLA-B37,B*3701,HUMAN,CANCER,P43358,Uniprot,TISSUE ANTIGENS 2002 60 365-371
SFLTALKRFL,CLASS-1,H2-d,H2-Kd,HUMAN,VIRAL,P03114,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2001 254 59-66
SFNCGGEFF,CLASS-1,HLA-B15,,HUMAN,VIRAL,P03375,Uniprot,JOURNAL OF VIROLOGY 1997 71 1256-1264
SFSIFLLALLSCLT,CLASS-1,H-2d,,MOUSE,VIRAL,P27954,Uniprot,HEPATOLOGY 1997 25 470-477
SGPERTIPITREEKPA,CLASS-1,H-2g,H-2Ag,MOUSE,SELF PEPTIDE,P23927,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 104 47-57
SGPSNIPPEI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03254,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3396-3405
SGPSNTPPEI,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03254,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; CELL 1989 59 603-614
SGPSRGRII,CLASS-1,H2-d,H2-Dd,MOUSE,VIRAL,P15632,Uniprot,JOURNAL OF GENERAL VIROLOGY 2002 83 311-316
SGVENPGGYCL,CLASS-1,H-2b; H-2b; H-2b; H-2b,H-2Db; H-2Kb,MOUSE,VIRAL,P09991,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 168 559-570; JOURNAL OF IMMUNOLOGY 1998 161 5087-5096; JOURNAL OF VIROLOGY 1995 69 2297-2305
SIANFEKL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667
SIFQSSMTK,CLASS-1,HLA-A3; HLA-A11,A*0301; A*1101,HUMAN,VIRAL,P03369,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
SIINFAKL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667
SIINFEAL,CLASS-1,H-2d,H-2Kd,MOUSE,MISCELLANEOUS,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667
SIINFEKL,CLASS-1,H-2d; H-2b; H-2b; H-2d; H-2b; H-2b; H-2b; H-2b; H-2b; H-2b; H-2b,H-2Kd; H-2Kb; H-2Ld; H-2Db,MOUSE,MISCELLANEOUS; CHICKEN; SELF PEPTIDE,P01012,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1992 22 2663-2667; ANNUAL REVIEW IMMUNOLOGY 1993 11 213-244; INFECTION AND IMMUNITY 1998 66 615-619; JOURNAL OF IMMUNOLOGY 1998 160 77-86; IMMUNITY 2001 14 231-242; JOURNAL OF IMMUNOLOGY 2001 167 4869-4877; METHODS IN ENZYMOLOGY 2000 326 527-542; PROC.NATL.ACAD.SCI. USA 2000 97 3485-3490; INFECTION AND IMMUNITY 2000 68 247-256; JOURNAL OF EXPERIMENTAL MEDICINE 1998 188 277-286
SIIPGLPLSL,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,P31748,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 1599-1607
SIISAVVGI,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
SIVLCCLCL,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03386,Uniprot,IMMUNOLOGY LETTERS 1998 62 33-38
SIVSPFIPLL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03142; P31873,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
SKGDLCGYRRCRASGVFTTS,CLASS-1,HLA-A3/A26/B38/B51,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
SLADTNSLAV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802; CORNEA 2000 19 S2-S6
SLAMLDLLHV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
SLASLFTSGA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P29846,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
SLDDYNHLV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2000 87 399-404; CANCER RESEARCH 1998 58 4895-4901
SLDQSVVEL,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P17451,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6855-6866
SLFEGIDFYT,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,Q01233,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1730-1738
SLFRAVITK,CLASS-1,HLA-A3,,HUMAN,CANCER,P43355,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2928-2936
SLGEQQYSV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P19544,Uniprot,IMMUNOGENETICS 2000 51 99-107
SLGVNIDLM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
SLHVGTQCA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
SLKEKGGL,CLASS-1,HLA-B8,,HUMAN,VIRAL,P18801,Uniprot,PROC.NATL.ACAD.SCI. USA 1997 94 1890-1895
SLLAPGAKQNV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742; HEPATOLOGY 2001 33 1533-1543; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
SLLLELEEV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P20916,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 10859-10863
SLLMWITQC,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A1; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P78358,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 265-270; JOURNAL OF IMMUNOTHERAPY 2001 24 1-9; CORNEA 2000 19 S2-S6
SLLMWITQCFL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A1; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P78358,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1998 187 265-270; JOURNAL OF IMMUNOTHERAPY 2001 24 1-9; CORNEA 2000 19 S2-S6
SLLMWITQV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P78358,Uniprot,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
SLLNATDIAV,CLASS-1,HLA-A2; HLA-A1,A*0201,HUMAN,VIRAL,P05877; P35961,Uniprot,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678; VACCINE 2001 19 4121-4129
SLLPAIVEL,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,P30153,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2216-2225
SLLQHLIGL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P78395,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
SLLYNLDLM,CLASS-1,H-2b,H-2Db,MOUSE,SYNTHETIC,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
SLMAFTAAV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26663; P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 95 521-530; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230
SLNFMGYVI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P12933,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
SLPPPGTRV,CLASS-1,HLA-A2,,HUMAN,CANCER,P04637,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
SLREWLLRI,CLASS-1,HLA-A2,A*0203,HUMAN,VIRAL,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 573-582
SLSAYIIRV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P20497,Uniprot,PROC.NATL.ACAD.SCI. USA 2003 100 217-222
SLSPFYLRPP,CLASS-1,H-2s,,MOUSE,SELF PEPTIDE,P23927,Uniprot,INTERNATIONAL IMMUNOLOGY 1998 10 943-950
SLSRFSWGA,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P02686,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 10859-10863
SLTANMKEV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
SLTPPHSAK,CLASS-1,HLA-A3; HLA-A3,,MOUSE; HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
SLVELTSL,CLASS-1,H-2b,H-2Kb,MOUSE,SELF PEPTIDE,P36972,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 13991-13996
SLVENALVV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
SLVIVTTFV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
SLVSWLSQGP,CLASS-1,H-2d,,MOUSE,VIRAL,P26662,Uniprot,GASTROENTEROLOGY 1998 115 954-965
SLYADSPSV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03156; P24024,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 1527-1534; EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
SLYNTIAVL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05889,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1423-1433
SLYNTVATL,CLASS-1,HLA-A2; HLA-A2; HLA-A1; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P05888; P05889,Uniprot,JOURNAL OF VIROLOGY 1996 70 5799-5806; JOURNAL OF IMMUNOLOGY 1998 161 4875-4881; VACCINE 2001 19 4121-4129; JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1423-1433
SLYSFPEPEA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P78395,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
SMVGNMAKV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27953,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
SMVGNWAKV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,Q00269,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2733-2742
SMVGNWAKVL,CLASS-1,HLA-A2; HLA-A2,,HUMAN,VIRAL,P27953,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415; JOURNAL OF MEDICAL VIROLOGY 2002 66 472-480
SNDGPTLI,CLASS-1,HLA-Cw8,,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 1739-1748
SNEGSYFF,CLASS-1,Saoe-G*01; Saoe-G*08,,TAMARIN,VIRAL,P03487,Uniprot,IMMUNOGENETICS 1998 47 206-211
SNFVFAGI,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 695-705
SNLNDATYQRTRALVRTGMDP,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P06826,Uniprot,CELL 1988 52 253-258
SNQEPLKL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P05133,Uniprot,JOURNAL OF MEDICAL VIROLOGY 2000 60 189-199
SPAIFQSSM,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P05959,Uniprot,AIDS 1996 10 1075-1083
SPAIFQSSMT,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12499,Uniprot,VACCINE 2001 19 4385-4395
SPFPFDLLL,CLASS-1,H-2d,H-2Ld,MOUSE,HUMAN,Q02218,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 11487-11491
SPGRSFSYF,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,P06830,Uniprot,VIROLOGY 1994 200 281-283
SPIETVPVKL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P12499,Uniprot,VACCINE 2001 19 4385-4395
SPPSTPLLY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
SPRWWPTCL,CLASS-1,HLA-B27,B*2702,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 483-490
SPSSNRIRNT,CLASS-1,HLA-B7,,HUMAN,CANCER,not applicable,Uniprot,IMMUNOGENETICS 1996 44 323-330
SPSVDKARAEL,CLASS-1,HLA-B7,,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 2750-2759
SPSYVYHQF,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,P03386,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 9730-9735
SQKVAKEGPRLSKNQKFSEHFS,CLASS-1,H-2S,,MOUSE,RAT,Q63343,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 102 189-198
SQQRNFQLL,CLASS-1,H2-b,H2-Db,MOUSE,SELF PEPTIDE,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2001 31 1239-1246
SRADKERLL,CLASS-1,H-2k,H-2Dk,MOUSE,VIRAL,P03076,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1724-1734
SRFWAIRTR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P03467,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
SRRLRLPSL,CLASS-1,H-2k; H-2k,H-2Dk,MOUSE,VIRAL,P03076,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3933-3941; JOURNAL OF IMMUNOLOGY 1998 160 1724-1734
SRRYPDAVYLH,CLASS-1,HLA-B27,,HUMAN,VIRAL,P08300,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 405-410
SRYWAIRKR,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P26089,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
SRYWAIRTK,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P26089,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 6879-6883
SRYWAIRTL,CLASS-1,HLA-B27,B*2705,HUMAN,VIRAL,P26089,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2357-2363
SRYWAIRTR,CLASS-1,HLA-B27; HLA-B27,B*2705,HUMAN,VIRAL,P03467,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 6879-6883; NATURE 1991 353 6342 326-329
SSDYVIPIGTY,CLASS-1,HLA-A1; HLA-A1,,HUMAN,SELF PEPTIDE,P14679,Uniprot,CORNEA 2000 19 S2-S6; JOURNAL OF IMMUNOLOGY 1998 161 6985-6992
SSIEFARL,CLASS-1,H-2b; H-2b,H-2Kb,MOUSE,VIRAL,P06437; P06436,Uniprot,VIROLOGY 1993 195 62-70; PROC.NATL.ACAD.SCI. USA 2000 97 3485-3490
SSKALQRPV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,not applicable,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2290-2296
SSVAYGRQVYLK,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
SSVIGVWYL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P54107,Uniprot,IMMUNITY 1997 7 461-472
SSVVGVWYL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,Q8TCT9,Uniprot,IMMUNITY 1997 7 461-472
SSWDFITV,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03385,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 1898-1905
SSYGQQSEK,CLASS-1,HLA-A3,,HUMAN,SELF PEPTIDE,Q01844,Uniprot,CANCER RESEARCH 2001 61 6868-6875
STAPPAHGV,CLASS-1,HLA-A11,A*1101,HUMAN,CANCER,P15941,Uniprot,VACCINE 2000 18 2059-2071
STAPPHVNV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,BLOOD 1999 93 4309-4317
STAPPVHNV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
STEPFPNQK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
STGLIHLHQ,CLASS-1,HLA-A2,,HUMAN,VIRAL,P29846,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
STLPETTVVRR,CLASS-1,HLA-A31; HLA-A68; HLA-A11; HLA-A31; HLA-A68; HLA-A31; HLA-A11; HLA-A68,A*31012; A*6801; A*3101,HUMAN,VIRAL,P03156; P03146; Q05495; P03150,Uniprot,GUT 2000 47 1 137-143; JOURNAL OF IMMUNOLOGY 1997 159 4753-4761; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; CANCER CHEMOTHERAPY PHARMACOLOGY 2000 46 S86-S90; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
STLQEQIGW,CLASS-1,HLA-B57,B*5701,HUMAN,VIRAL,P04594,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 2191-2201
STNPKPQK,CLASS-1,HLA-A11; HLA-A11,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF VIROLOGY 1993 67 7522-7532; CELLULAR IMMUNOLOGY 2000 203 111-123
STPPLVRLV,CLASS-1,,Mamu-A*01,RHUESUS; CHIMPANZEE,VIRAL,P27973; P12502,Uniprot,JOURNAL OF VIROLOGY 1999 73 5466-5472; VIRAL IMMUNOLOGY 2001 14 369-377
STPPPGTRV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P04637,Uniprot,JOURNAL OF SURG. RES. 1997 69 337-343; PROC.NATL.ACAD.SCI. USA 1995 92 11993-11997; JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 833-841; SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2001 53 357-364
STPPPTRV,CLASS-1,HLA-A2; HLA-A2,,HUMAN,HUMAN; SELF PEPTIDE,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
STVKDLLPLLEKVIG,CLASS-1,RT1.Bl,,RAT Lewis,BACTERIAL,Q49093,Uniprot,JOURNAL OF IMMUNOLOGY 1994 152 3656-3664
SVAQEIVEEDA,CLASS-1,H-2k/d,,MOUSE,PARASITE,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 379-389
SVDEQIQWM,CLASS-1,Mafa-A2,,MACAQUE,VIRAL,P05893,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2516-2522
SVEINCTRPNNNTRKSI,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03375,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
SVIGFLAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P05133,Uniprot,JOURNAL OF MEDICAL VIROLOGY 2000 60 189-199
SVKKDLISY,CLASS-1,HLA-B62,,HUMAN,VIRAL,P33478,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2754-2760
SVRDRLARL,CLASS-1,HLA-A2; HLA-A2,A*0201; A*0203,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF GENERAL VIROLOGY 1994 75 2489-2493
SVSYFKCV,CLASS-1,H-2b,H-2Kb,MOUSE,SELF PEPTIDE,P25322,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 239-246
SVVEFSSL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 13991-13996
SVYDFFVWL,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901; CORNEA 2000 19 S2-S6
SWAIKWEY,CLASS-1,,Patr-A*11,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1761-1775
SYIGSINNI,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P04545,Uniprot,JOURNAL OF VIROLOGY 1993 67 4086-4092
SYIPSAEKI,CLASS-1,H-2d; H-2d; H-2d,H-2Kd,MOUSE,PARASITE,P23093; P06915,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612; NATURE 1989 341 6240 323-326; JOURNAL OF GENERAL VIROLOGY 1998 79 83-90
SYIPSAEKIL,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P23093,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
SYIPSAEKILE,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P23093,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
SYLDSGIHF,CLASS-1,HLA-A24; HLA-A24; HLA-A24,,HUMAN,CANCER,P35222,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1185-1192; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
SYLQDSDPDSFQD,CLASS-1,HLA-DR4,,HUMAN,SELF PEPTIDE,P14679,Uniprot,CORNEA 2000 19 S2-S6
SYNAELLVAL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03439,Uniprot,VIROLOGY 1995 214 445-452
SYTRLFLILN,CLASS-1,HLA-A24,,HUMAN,SELF PEPTIDE,Q9UL01,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 2565-2574
SYVPSAEQI,CLASS-1,H-2d; H-2d; HLA-A2,H-2Kd; A*0201,MOUSE; HUMAN,PARASITE,P06914,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612; VACCINE 2000 18 1863-1869; PARASITE IMMUNOLOGY 2000 22 501-514
TAAYWEICKYLKEG,CLASS-1,H-2d,,MOUSE,NEMATODE,P29030,Uniprot,VACCINE 2002 20 3685-3694
TAFTIPSI,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P03366,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 3260-3267
TAFTIPSIY,CLASS-1,HLA-B51,B*5101,HUMAN,VIRAL,P03366,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
TAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
TAVPWNASW,CLASS-1,HLA-B35; HLA-B35; HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P04582,Uniprot,JOURNAL OF VIROLOGY 1994 68 3145-3153; AIDS 1996 10 1075-1083
TELEISSI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,Q01552,Uniprot,JOURNAL OF VIROLOGY 2001 75 8579-8588
TELRTFSI,CLASS-1,H-2k,,MOUSE,VIRAL,P87671,Uniprot,VACCINE 1999 17 2991-2998
TEMEKEGKI,CLASS-1,H-2k,H-2Kk,MOUSE,VIRAL,P20875,Uniprot,PROC.NATL.ACAD.SCI. USA 1990 87 2344-2348
TENSGKDI,CLASS-1,H-2k,H-2Kk,MOUSE,SELF PEPTIDE,P79457,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 2750-2759
TFAPSTIF,CLASS-1,Saoe-G*06; Saoe-G*04,,TAMARIN,MISCELLANEOUS,not applicable,Uniprot,IMMUNITY 1995 3 583-590
TFLNSKREIVDRKYSICKSGC,CLASS-1,H-2S,,MOUSE,RAT,Q63343,Uniprot,JOURNAL OF NEUROIMMUNOLOGY 2000 102 189-198
TFPDLESEF,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,P43357,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
TFRHSVVV,CLASS-1,HLA-A24,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
TGAPVTYSTY,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF VIROLOGY 1996 70 232-240
TGHDWILA,CLASS-1,HLA-B3.2,,HUMAN,VIRAL,P03314,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
TGPPDADGI,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,Q08097,Uniprot,VACCINE 1999 17 686-694
TGQAPGFSYT,CLASS-1,H-2b; H-2b,H-2Kb; H-2Db,MOUSE,SELF PEPTIDE,P00015,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2141-2149
THYLFRNL,CLASS-1,H-2b,H-2Kb,MOUSE,MISCELLANEOUS,not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 121-130
TILLGIFFL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
TIMAFRWVT,CLASS-1,HLA-A2,,HUMAN,n/a,not applicable,Uniprot,BRITISH JOURNAL OF CANCER 2002 87 1006-1012
TINFESTGNLIAPEYGF,CLASS-2; CLASS-1,I-Ad; H-2k,H-2Kk,MOUSE,VIRAL,P03451,Uniprot,NATURE 1989 342 6246 180-182
TINYTIFK,CLASS-1,HLA-A11; HLA-A11; HLA-A11,A*1101,HUMAN,VIRAL,P26664; P26660; P27958,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321; CELLULAR IMMUNOLOGY 2000 203 111-123
TINYTIFKI,CLASS-1,Patr-B*2001; Patr-A*2001,,CHIMPANZEE,VIRAL,P26664,Uniprot,IMMUNITY 1999 10 439-449; IMMUNITY 2001 15 883-895
TITDQVPFSV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968; INTERNATIONAL IMMUNOLOGY 1997 9 327-338
TITTGSPITYS,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
T(I/V)NYTIFK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P26660,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
TIYQYMDDL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P12499,Uniprot,JOURNAL OF INFECTIOUS DISEASES 1996 173 476-479
TKPAIRRLARRGGVKRIS,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
TKRNTNRRPMDVKFPGGGQI,CLASS-1,HLA-A1/A24/B35,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
TLAPATERA,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P15941,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
TLDSQVMSL,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246; CANCER RESEARCH 1998 58 4895-4901
TLEEFSAKL,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,Q9U6Z1,Uniprot,MOLECULAR IMMUNOLOGY 2001 38 279-287
TLFIGSHVV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03231,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
TLGFGAYMSK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
TLGIVCPI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2281-2289
TLGIVCPIC,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
TLHCDCEIL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q02080,Uniprot,CANCER RESEARCH 2000 60 6448-6456
TLHEYMLDL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
TLKGHNGW,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,P25388,Uniprot,IMMUNOGENETICS 1998 48 56-61
TLLRKERGV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q9UBX1,Uniprot,CANCER RESEARCH 2001 61 2038-2046
TLLVDLLWL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03230http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2003 101 3150-3156
TLNAWVKVV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05888,Uniprot,JOURNAL OF IMMUNOLOGY 1994 152 163-175
TLQDIVLHL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P06788,Uniprot,CLINICAL CANCER RESEARCH 2001 7 S788-S795
TLSNVEVFM,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q13296,Uniprot,SURGERY 2003 133 74-80
TLTCGFADL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
TLTHPITK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P27958,Uniprot,CELLULAR IMMUNOLOGY 2000 203 111-123
TLTHPVTK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
TLWKAGILYK,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
TLYCVHQR,CLASS-1,HLA-A11,A*0101,HUMAN,VIRAL,P05889,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 4875-4881
TMYGGISLL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P13202,Uniprot,JOURNAL OF VIROLOGY 2003 77 4457-4462
TNLLNDRVL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P25322,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 239-246
TNNRARRELPPF,CLASS-1,HLA-B57,,HUMAN,VIRAL,P03420,Uniprot,JOURNAL OF VIROLOGY 2000 74 10240-10244
TPAETTVRL,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P26663; Q00269,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744; AIDS 1998 12 2073-2074
TPARVTGGVF,CLASS-1,HLA-B51,,HUMAN,VIRAL,P03156,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
TPEGIIPTL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P09866,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 1287-1295
TPGPGVRYPL,CLASS-1,HLA-B7; HLA-B7; HLA-B7,,HUMAN,VIRAL,P12479; P05855,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221; JOURNAL OF VIROLOGY 1994 68 7336-7343; JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
TPHPARIGL,CLASS-1,H-2d; H-2d; H-2d,H-2Ld,MOUSE,BACTERIAL,P00722,Uniprot,JOURNAL OF IMMUNOLOGY 1993 151 3971-3980; MOLECULAR IMMUNOLOGY 1997 34 273-281
TPQDLNTML,CLASS-1,HLA-B7,,HUMAN,VIRAL,P03350,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
TPQDLNTMLN,CLASS-1,HLA-B14,,HUMAN,VIRAL,P05889,Uniprot,VACCINE 2001 19 4385-4395
TPQVPLRPMTY,CLASS-1,HLA-B7; HLA-B35,,HUMAN,VIRAL,P03404,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
TPRVTGGGAM,CLASS-1,HLA-B7; HLA-B7,B*0702,HUMAN,VIRAL,P18139,Uniprot,BLOOD 2001 98 1872-1881; HUMAN IMMUNOLOGY 2003 64 440-452
TQATTPAPKVAE,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
TQGYFPDWQ,CLASS-1,HLA-B37,B*3701,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
TQGYFPDWQNYT,CLASS-1,HLA-B17,,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
TQNHRALDL,CLASS-1,H-2d; H-2d,H-2Ld,MOUSE,CANCER; SELF PEPTIDE,P14685,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 273-281; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2001 289 825-831
TRPPLGNWF,CLASS-1,,Patr-B*13,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1761-1775
TRPRVTGGGAM,CLASS-1,HLA-B7,,HUMAN,VIRAL,P06725,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
TSAPDTRPA,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P15941,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2579-2587
TSEHSHFSL,CLASS-1,HLA-B35,,HUMAN,SELF PEPTIDE,Q05329,Uniprot,HUMAN IMMUNOLOGY 1999 60 652-664
TSINFVKI,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 868-874
TSPRNSTVL,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P31996,Uniprot,IMMUNITY 1998 9 687-698
TSSIEFARLQF,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P06436,Uniprot,VIROLOGY 1993 195 62-70
TTAEEAAGI,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
TTIHYKYM,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P02340,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 239-246
TTINYTLWR,CLASS-1,HLA-A11,,HUMAN,CANCER,P43356,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
TTNAIDELK,CLASS-1,HLA-A3,,HUMAN,SELF PEPTIDE,Q13296,Uniprot,INTERNATIONAL JOURNAL OF CANCER 2002 102 499-506
TTYQRTRAL,CLASS-1,HLA-B14,,HUMAN,VIRAL,P21433,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1994 269 32426-32434
TVATRDGKL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
TVILGVLLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
TVLDVGDAY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P20892,Uniprot,JOURNAL OF VIROLOGY 1999 73 3975-3985
TVPWPNETL,CLASS-1,,Mamu-A*01,RHUESUS,VIRAL,P15831,Uniprot,JOURNAL OF VIROLOGY 1999 73 8035-8039
TVYYGVPVWK,CLASS-1,HLA-A11; HLA-A11,,HUMAN,VIRAL,P19551; P12490,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
TYACFVSNL,CLASS-1,HLA-A24; HLA-A24,A*2402,HUMAN,CANCER,P06731,Uniprot,CANCER IMMUNOLOGY IMMUNOTHERERAPY 1998 47 90-96; INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
TYQRTRALV,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P21931,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
TYQRTRALVRG,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P06826,Uniprot,CELL 1988 52 253-258
TYQRTRALVRGA,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P06826,Uniprot,CELL 1988 52 253-258
TYQRTRALVRTG,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P21433,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
TYQRTRALVTG,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P18277,Uniprot,NATURE 1990 348 6298 252-254
TYQRTRALVTTG,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P06826,Uniprot,CELL 1988 52 253-258
TYSAGIVQI,CLASS-1,HLA-A24,,HUMAN,VIRAL,P03203http://www.expasy.ch/cgi-bin/get-sprot-entry,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
TYSPALNKMF,CLASS-1,HLA-A24,,HUMAN,HUMAN,P04637,Uniprot,HUMAN IMMUNOLOGY 2001 62 791-798
TYVSVGTSTI,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03439,Uniprot,NATURE 1995 378 6554 295-298
TYVSVGTSTL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03439,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 176 1335-1341
TYVSVSTSTL,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P03439,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1994 179 195-202
VAGALVAFK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P26664,Uniprot,HUMAN IMMUNOLOGY 2003 64 497-504
VAITRIEQLSPFPFDL,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q60597,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
VAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
VAYGRQVYLKLS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
VCDKCLKFY,CLASS-1,HLA-B18,,HUMAN,VIRAL,P03126,Uniprot,IMMUNOLOGY 1991 72 3-9
VDGIGILTI,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,Q01976,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 647-657
VDYNFTIV,CLASS-1,H-2b; HLA-A2,H-2Kb; A*0201,MOUSE; HUMAN,PARASITE,not applicable; P18269,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 6120-6130; JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
VEITPYKPTW,CLASS-1,HLA-B44,,HUMAN,VIRAL,P03203,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
VEPTKDVAL,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
VERWNEKYAQAY,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
VESPGQLI,CLASS-1,H-2k; H-2k; H-2k,H-2Kk,MOUSE,VIRAL,P04851,Uniprot,VIROLOGY 1994 203 172-177; JOURNAL OF GENERAL VIROLOGY 2000 81 2707-2713; VIROLOGY 1994 203 172-777
VESPGQU,CLASS-1,H-2k,H-2Kk,MOUSE,MISCELLANEOUS,not applicable,Uniprot,VIROLOGY 1994 203 172-177
VFPTKDVALRH,CLASS-1,HLA-A33,,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
VFSDGRVAC,CLASS-1,HLA-A29,,HUMAN,VIRAL,P12977,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
VGGVYLLPRRGPRLGVRATR,CLASS-1,HLA-A3/A24/B49/B56,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
VGIYLLPNR,CLASS-1,HLA-A31,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF IMMUNOLOGY 1998 160 1479-1488
VGPVFPPGM,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03530,Uniprot,JOURNAL OF GENERAL VIROLOGY 1993 74 2579-2586
VHPVHAGPIA,CLASS-1,HLA-B55,B*5501,HUMAN,VIRAL,P03348,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
VILGVLLLI,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
VIQVVSTIK,CLASS-1,HLA-A11,,HUMAN,BACTERIAL,not applicable,Uniprot,JOURNAL OF MOLECULAR GRAPHICS AND MODELLING 2001 19 405-411
VISNDVCAQV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P07288,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 3186-3194
VIYQYMDDL,CLASS-1,HLA-A2; HLA-A2; HLA-A1,A*0201,HUMAN,VIRAL,P03366; P04589,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 2616-2623; JOURNAL OF INFECTIOUS DISEASES 1996 173 476-479; VACCINE 2001 19 4121-4129
VKIEPLGVAPTKAKRRVVQR,CLASS-1,HLA-A2,,HUMAN,VIRAL,P04582,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
VKTDGNPPEV,CLASS-1,HLA-A2,A*0201,HUMAN,BACTERIAL,P11572,Uniprot,JOURNAL OF IMMUNOLOGY 1998 161 2400-2406
VKYGVSVQDIMS,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
VLAALAAYCL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,HEPATOLOGY 2001 33 1533-1543
VLAEAMSQV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03349,Uniprot,JOURNAL OF VIROLOGY 2001 75 1301-1311
VLAKDGTEV,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,not applicable,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
VLDKVEETV,CLASS-1,HLA-A2,,HUMAN,PARASITE,Q9U0N9,Uniprot,INFECTION AND IMMUNITY 2000 68 227-232
VLEETSVML,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P13202,Uniprot,HUMAN IMMUNOLOGY 2003 64 440-452
VLETAVGLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q01726,Uniprot,CANCER RESEARCH 1997 57 4348-4355
VLEWRFDSRL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P05855,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221
VLFSSDFRI,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P20916,Uniprot,PROC.NATL.ACAD.SCI. USA 1994 91 10859-10863
VLFWRFDSRL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P19546,Uniprot,JOURNAL OF IMMUNOLOGY 1996 157 4212-4221
VLGPISGHV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P06725; P18139,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518; BLOOD 2001 98 1872-1881
VLHSFTDAI,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
VLLPSLFLL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P18269,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
VLLPSLFLLL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P18269,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
VLLWEIFSL,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,P29376,Uniprot,BLOOD 2002 99 2100-2106
VLMAVVLASL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
VLPDVFIRC,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL; SYNTHETIC,P19504; not applicable,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1131-1140; CORNEA 2000 19 S2-S6
VLPDVFIRCV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P19504,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1131-1140
VLQAGFFIL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P31873,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
VLQWASLAV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,Q07284,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3063-3069
VLRENTSPK,CLASS-1,HLA-A3,A*0301,HUMAN,CANCER,P04626,Uniprot,CANCER RESEARCH 1999 59 431-435
VLSDFKTWL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26662,Uniprot,HEPATOLOGY 2001 33 1533-1543
VLSVNVPDV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 2000 60 6448-6456
VLTDGNPPEV,CLASS-1,HLA-A2,,HUMAN,BACTERIAL,P11572,Uniprot,IMMUNOLOGY 2001 104 278-288
VLVKSPNHV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,ANTICANCER RESEARCH 1997 17 1A 45-53; JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 2109-2117
VLYRYGSFSV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1999 82 669-677; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CELLULAR IMMUNOLOGY 2000 204 29-37; CORNEA 2000 19 S2-S6
VMAGVGSPYV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,HUMAN IMMUNOLOGY 1997 52 109-118
VMGTLVALV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901; INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
VMNILLQYVV,CLASS-1,HLA-A2,A*0201,HUMAN,SELF PEPTIDE,Q05329,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1923-1927
VMSNTLLSAW,CLASS-1,HLA-A25,,HUMAN,VIRAL,P13285,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
VNIRNCCYI,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03243,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3396-3405
VPAPAGPIV,CLASS-1,HLA-B7,,HUMAN,VIRAL,P12977,Uniprot,ANNUAL REVIEW IMMUNOLOGY 1997 15 405-431
VPASQVCGPVY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
VPHPNIEEV,CLASS-1,,Patr-B*13,CHIMPANZEE,VIRAL,P26663,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1761-1775
VPLDEDFRKY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P03369,Uniprot,AIDS 1996 10 1075-1083
VPLDKDFRKY,CLASS-1,HLA-B35; HLA-B35,B*3501,HUMAN,VIRAL,P03369,Uniprot,AIDS 1996 10 1075-1083; JOURNAL OF CLINICAL INVESTIGATION 1997 99 752-762
VPLRPMTY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P15829,Uniprot,JOURNAL OF VIROLOGY 1994 68 7336-7343
VPLRPMTYK,CLASS-1,HLA-A11,A*1101,HUMAN,VIRAL,P18801,Uniprot,PROC.NATL.ACAD.SCI. USA 1993 90 2217-2221
VPLRPVGNIY,CLASS-1,HLA-B35,,HUMAN,MISCELLANEOUS,not applicable,Uniprot,NATIONAL MEDICINE 1995 1 59-64
VPSPPSTPLLY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
VPSPSSTPLL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
VPSPSSTPLLY,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
VPSSSSTPL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
VPVWKEATTT,CLASS-1,HLA-B55,B*5501,HUMAN,VIRAL,P04579,Uniprot,IMMUNOLOGY INVEST. 1995 24 489-497
VQNEITLTH,CLASS-1,Patr-A*0101,,CHIMPANZEE,VIRAL,Q00269,Uniprot,IMMUNITY 2001 15 883-895
VRIGHLYIL,CLASS-1,HLA-Cw7; HLA-Cw7,Cw*0702,HUMAN,CANCER,P43365,Uniprot,JOURNAL OF IMMUNOLOGY 2000 164 4382-4392; JOURNAL OF IMMUNOLOGY 2000 164 6041-6045
VSAINNYAQKL,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,VIRAL,P03070,Uniprot,JOURNAL OF VIROLOGY 1992 66 440-447; INTERNATIONAL IMMUNOLOGY 1998 10 463-472
VSDGGPNLY,CLASS-1,HLA-B18; HLA-A1,,HUMAN,VIRAL,P16504,Uniprot,IMMUNOLOGY 1991 72 3-9
VTVYYGVPVWK,CLASS-1,HLA-A11,,HUMAN,VIRAL,P19551,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
VTWHRYHLL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
VVGEEKLVSEE,CLASS-1,H-2k/d,,MOUSE,PARASITE,not applicable,Uniprot,MOLECULAR IMMUNOLOGY 1997 34 379-389
VVLGVVFGI,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
VVMGTLVAL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
VVYDFLKC,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03070,Uniprot,JOURNAL OF VIROLOGY 1995 69 6665-6677
VYALPLKML,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
VYDFFVWL,CLASS-1,H-2b,H-2Kb,MOUSE,CANCER,P40126,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 453-459
VYDFLKCM,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P03070,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2016-2023
VYDYNCHVDL,CLASS-1,HLA-A24,A*2402,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 1999 59 4056-4063
VYFFLPDHL,CLASS-1,HLA-A24; HLA-A24,,HUMAN,MISCELLANEOUS; SELF PEPTIDE,not applicable; P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1997 159 303-308; CORNEA 2000 19 S2-S6
VYQCCNLEPEARKAITALTE,n/a; CLASS-1,HLA-A3/A33/B35/B38,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF HEPATOLOGY 2004 40 313-318
VYRDGNPYA,CLASS-1,H-2b,,HUMAN,VIRAL,P03126,Uniprot,VIRAL IMMUNOLOGY 1999 12 297-312
VYVKTSSFI,CLASS-1,H-2d,H-2Kd,MOUSE,FLY,Q24019,Uniprot,JOURNAL OF IMMUNOLOGY 2001 167 655-666
VYYGVPVWK,CLASS-1,HLA-A3,,HUMAN,VIRAL,P19549,Uniprot,JOURNAL OF VIROLOGY 1994 68 3145-3153
VYYTSAFVF,CLASS-1,HLA-A24,,HUMAN,VIRAL,P06725,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
WASHNMDPI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
WASRELERF,CLASS-1,HLA-B35,,HUMAN,VIRAL,P03350,Uniprot,AIDS 1997 11 930-932
WGPPMRHAL,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,P27599,Uniprot,VACCINE 1999 17 686-694
WHYPPKPCGI,CLASS-1,HLA-B41,,HUMAN,VIRAL,P27960,Uniprot,JOURNAL OF VIROLOGY 1993 67 7522-7532
WILRGTSFV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P12933,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
WLPFGFILI,CLASS-1,HLA-A2,,HUMAN,SELF PEPTIDE,Q14627,Uniprot,CLINICAL CANCER RESEARCH 2002 8 2851-2855
WLPKILGEV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,not applicable,Uniprot,CANCER RESEARCH 2000 60 6448-6456
WLSLLVPFV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201; A*0202,HUMAN,VIRAL,P12934; P24025; P31873,Uniprot,JOURNAL OF IMMUNOLOGY 1993 150 4659-4671; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925; JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513; JOURNAL OF CLINICAL INVESTIGATION 1996 97 1655-1665; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
WMGHNAIVI,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
WMHHNMDLI,CLASS-1,H-2b; H-2b,H-2Db,MOUSE,SELF PEPTIDE,P79457,Uniprot,NATIONAL GENETICS 1996 14 474-478; JOURNAL OF IMMUNOLOGY 1997 159 2750-2759
WNTGHDWILA,CLASS-1,HLA-A3; HLA-A10,A*0307; A*1029,HUMAN,VIRAL,P03314,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
WPTLIGLAM,CLASS-1,HLA-B35,B*3501,HUMAN,BACTERIAL,P31953,Uniprot,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
WPTVRERM,CLASS-1,HLA-B8,,HUMAN,VIRAL,P05857,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 1515-1521
WSKDNLPNG,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P03304,Uniprot,JOURNAL OF VIROLOGY 1997 71 5361-5365
WTEAQRLDCWRGGQ,CLASS-1,HLA-B35,B*3501,HUMAN,SELF PEPTIDE,P40967,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
WTGHNGDVM,CLASS-1,H-2b,H-2Db,MOUSE,MISCELLANEOUS,not applicable,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2124-2133
WYKTGISNI,CLASS-1,H2-d,H2-Kd,HUMAN,VIRAL,P03114,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2001 254 59-66
YAAGIGILTV,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,Q16655,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1997 27 2366-2374
YADDIEKKI,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P02893,Uniprot,INFECTION AND IMMUNITY 1995 63 1955-1959
YAIDLPVSV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901; CANCER RESEARCH 2001 61 1089-1094
YALKRQGRTLYG,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
YAMIYRNL,CLASS-1,H-2b; H-2b,H-2Kb,MOUSE,SELF PEPTIDE,P23804,Uniprot,PROC.NATL.ACAD.SCI. USA 1996 93 13114-13118; JOURNAL OF IMMUNOLOGY 1996 157 239-246
YANDIEKKI,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P02893,Uniprot,INFECTION AND IMMUNITY 1995 63 1955-1959
YAPGNYPAL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P04857,Uniprot,JOURNAL OF IMMUNOLOGY 1995 155 2841-2848
YAPPISGQI,CLASS-1,,Mamu-B*12,RHUESUS,VIRAL,P05888,Uniprot,JOURNAL OF VIROLOGY 1999 73 5466-5472
YAPPITGQI,CLASS-1,Mamu-A*01; Mamu-A*01,,CHIMPANZEE,VIRAL,P04582,Uniprot,VIRAL IMMUNOLOGY 2001 14 369-377
YASTTRISESQA,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
YDNAGTNL,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P13814,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 4134-4141
YENDIEKKI,CLASS-1,H-2k,H-2Kk,MOUSE,PARASITE,P02893,Uniprot,INFECTION AND IMMUNITY 1995 63 1955-1959
YFPDWQNYT,CLASS-1,HLA-B37; HLA-B57,,HUMAN,VIRAL,P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
YGPSLYRRF,CLASS-1,H-2d,H-2Dd,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
YGVSVQDIMSWN,CLASS-1,H-2d,,MOUSE,BACTERIAL,Q01836,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
YHTQGYFPDWQ,CLASS-1,HLA-B17,,HUMAN,VIRAL,P20867,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565
YIASNENMETMESSTLE,CLASS-1,H-2b,H-2Db,MOUSE,VIRAL,P18277,Uniprot,NATURE 1991 352 6330 67-70
YIDDVVLGA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P12933,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
YIGEVLVSV,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,not applicable,Uniprot,SCIENCE 1995 268 5216 1476-1480
YIKSFVSDA,CLASS-1,HLA-B8,,HUMAN,VIRAL,P12977,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 184 1801-1813
YILEETSVML,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P13202,Uniprot,JOURNAL OF IMMUNOLOGY 2003 170 2030-2036
YIPLVGAPL,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27959,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
YIPSAEKI,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P23093,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
YISAWPDSL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
YISLCLWW,CLASS-1,HLA-A23,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
YISWCLWW,CLASS-1,HLA-A23; HLA-A23,,HUMAN,VIRAL,P26664,Uniprot,JOURNAL OF CLINICAL INVESTIGATION 1995 96 2311-2321
YKGDNEYIVVEK,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
YKKALGFVFKLDK,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1991 139 41-47
YKKALGFVFTLDK,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03487,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 1991 139 41-47
YKLVVVGAVGVGK,CLASS-1,H-2d,,MOUSE,SELF PEPTIDE,Q61411,Uniprot,CELLULAR IMMUNOLOGY 2000 205 73-83
YKRWIILGLNKIVRMYSPT,CLASS-1,HLA-A2,,HUMAN,VIRAL,P05889,Uniprot,JOURNAL OF IMMUNOLOGY 1991 147 2302-2309
YLAGLLTMV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P13285,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 4246-4271
YLENGKETL,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30495,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
YLENGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30513,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
YLENGKETLQRADPPK,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30513,Uniprot,NATURE 1986 324 6097 578-579
YLENGKETLQRTDPPK,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30513,Uniprot,NATURE 1986 324 6097 578-579
YLEPGPVTA,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0206; A*0211; A*0204; A*0201,HUMAN,CANCER; SELF PEPTIDE,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1996 156 3882-3891; INTERNATIONAL JOURNAL OF CANCER 1999 82 669-677; JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 363-368; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396; CORNEA 2000 19 S2-S6
YLEPGPVTAQ,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40967,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
YLGEVIVSV,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,not applicable,Uniprot,SCIENCE 1995 268 5216 1476-1480
YLGEVLVSV,CLASS-1,HLA-A2,A*0201,HUMAN,MISCELLANEOUS,not applicable,Uniprot,SCIENCE 1995 268 5216 1476-1480
YLGSYGFRL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04637,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
YLKDQQLL,CLASS-1,HLA-B8; HLA-B8; HLA-A24; HLA-A24,,HUMAN,VIRAL,P04578,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1992 175 961-971; JOURNAL OF VIROLOGY 1992 66 3151-3154
YLKEPVHGV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P20892,Uniprot,PROC.NATL.ACAD.SCI. USA 1995 92 8166-8170
YLKKIKNSL,CLASS-1,H-2d,H-2Kd,MOUSE,PARASITE,P13814,Uniprot,JOURNAL OF IMMUNOLOGY 1994 153 4134-4141
YLKNGKETLQRA,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30503,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1988 167 1391-1405
YLKNGKETLQRAEHPK,CLASS-1,H-2d,H-2Kd,MOUSE,SELF PEPTIDE,P30503,Uniprot,NATURE 1986 324 6097 578-579
YLKRKRIF,CLASS-1,HLA-B8,B*0802,HUMAN,MISCELLANEOUS,not applicable,Uniprot,IMMUNOGENETICS 1998 48 56-61
YLKSKGAEI,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,not applicable,Uniprot,IMMUNOGENETICS 1998 48 56-61
YLKVKGNVF,CLASS-1,HLA-B8,B*0802,HUMAN,SELF PEPTIDE,P14118,Uniprot,IMMUNOGENETICS 1998 48 56-61
YLLEMLWRL,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03230,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 4246-4271; BLOOD 2003 101 3150-3156
YLLPAIVHI,CLASS-1,HLA-A2,,HUMAN,MOUSE,Q61656,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2216-2225
YLLPRRGPRL,CLASS-1,HLA-A2; HLA-A2; H-2d; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN; MOUSE,VIRAL,P27958; P26664; P27959,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101; JOURNAL OF CLINICAL INVESTIGATION 1997 100 2376-2385; HEPATOLOGY 1997 25 470-477; JOURNAL OF CLINICAL INVESTIGATION 1996 98 1432-1440; JOURNAL OF VIROLOGY 1995 69 2462-2470; JOURNAL OF VIRAL HEPATITIS 2002 9 18-28; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87; HUMAN IMMUNOLOGY 2003 64 497-504; HUMAN IMMUNOLOGY 2003 64 224-230; CELLULAR IMMUNOLOGY 2000 203 111-123
YLNKIQNSL,CLASS-1,HLA-A2,A*0201,HUMAN,PARASITE,P19597,Uniprot,JOURNAL OF IMMUNOLOGY 1995 154 3922-3931
YLQLVFGIEV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P43356,Uniprot,INTERNATIONAL JOURNAL OF CANCER 1997 73 125-130; CLINICAL CANCER RESEARCH 1999 5 2236-2241
YLQQNWWTL,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03230http://ca.expasy.org/cgi-bin/get-sprot-entry,Uniprot,BLOOD 2003 101 3150-3156
YLSGANLNL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P06731,Uniprot,JOURNAL OF NATURE CANCER INSTITUTE 1995 87 982-990
YLVAYQATV,CLASS-1,HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P27958; P26663,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
YLVTRHADV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P26663,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
YMDDVVLGA,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,VIRAL,P03156; P12933,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101; JOURNAL OF IMMUNOLOGY 1999 162 3915-3925; JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
YMDDVVLGV,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03156,Uniprot,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
YMDGTMSQV,CLASS-1,HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER; SELF PEPTIDE,P14679,Uniprot,CANCER RESEARCH 1999 59 4050-4055; JOURNAL OF IMMUNOTHERAPY 2001 24 212-220; CORNEA 2000 19 S2-S6
YMIMVKCWMI,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P04626,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
YMLDLQPETT,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P03129,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2281-2289
YMNGTMSQV,CLASS-1,HLA-A2; HLA-A2; HLA-A2; HLA-A2; HLA-A2,A*0201,HUMAN,CANCER,P14679,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1994 24 759-764; INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; JOURNAL OF IMMUNOTHERAPY 2001 24 212-220; INTERNATIONAL JOURNAL OF CANCER 1995 61 389-396
YNAAGGHNA,CLASS-1,H-2d,H-2Kd,MOUSE,BACTERIAL,Q49575,Uniprot,INFECTION AND IMMUNITY 1999 67 4312-4319
YPAEITLTW,CLASS-1,HLA-B53,B*5301,HUMAN,SELF PEPTIDE,P10319,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 367-371
YPALGLHEF,CLASS-1,H-2d; H-2d; H-2d,H-2Ld,MOUSE,VIRAL,P04851; not applicable,Uniprot,JOURNAL OF GENERAL VIROLOGY 1993 74 2357-2363; JOURNAL OF GENERAL VIROLOGY 2000 81 2707-2713; MOLECULAR IMMUNOLOGY 1997 34 273-281
YPGRVNEIL,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03345,Uniprot,VIROLOGY 1996 226 102-112
YPHFMPTNL,CLASS-1,H-2d; H-2d; H-2d; H-2b; H-2d; H-2d; H-2d; H-2d,H-2Ld; H-2Kb,MOUSE,VIRAL,P11210,Uniprot,NATURE 1986 324 6097 578-579; NATURE 1989 337 6208 651-653; JOURNAL OF IMMUNOLOGY 1998 160 77-86; MOLECULAR IMMUNOLOGY 1997 34 273-281; JOURNAL OF IMMUNOLOGY 2001 166 3028-3034; BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2001 289 825-831; JOURNAL OF VIROLOGY 2002 76 151-164
YPLHEQHGM,CLASS-1,HLA-B35; HLA-B35; HLA-B35; HLA-B35,B*3501; B*3503,HUMAN,VIRAL,P12977,Uniprot,IMMUNITY 1995 3 591-600; EURO.JOURNAL OF IMMUNOLOGY 1995 25 102-110; EURO.JOURNAL OF IMMUNOLOGY 1999 29 1587-1597
YPLHEQHSM,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 102-110
YPLHQQHGM,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P12977,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 1995 25 102-110
YPLTEGWCY,CLASS-1,HLA-B35,,HUMAN,VIRAL,P05855,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 6164-6169
YPLTFGWCY,CLASS-1,HLA-B18; HLA-B18,,HUMAN,VIRAL,P12479; P03405,Uniprot,JOURNAL OF IMMUNOLOGY 1991 146 1560-1565; JOURNAL OF VIROLOGY 1994 68 7336-7343
YPNVNIHNF,CLASS-1,H-2d,H-2Ld,MOUSE,SELF PEPTIDE,Q62261,Uniprot,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2001 289 825-831
YPSKEPFNF,CLASS-1,H-2d,H-2Ld,MOUSE,VIRAL,not applicable,Uniprot,JOURNAL OF VIROLOGY 2002 76 151-164
YPSLALAPA,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
YPSLALAPH,CLASS-1,HLA-B35,B*3501,HUMAN,VIRAL,P03381,Uniprot,VIROLOGY 1996 226 102-112
YQGSYGFRL,CLASS-1,HLA-A2,,HUMAN,CANCER,P04637,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
YQRTRALV,CLASS-1,H-2d,H-2Kd,MOUSE,VIRAL,P18069,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1991 174 603-612
YRPRPRRY,CLASS-1,HLA-Cw6; HLA-Cw6; HLA-Cw6,,HUMAN,CANCER; SELF PEPTIDE,Q13065,Uniprot,INTERNATIONAL IMMUNOLOGY 1997 9 327-338; KEIO JOURNAL OF MEDICINE 1996 45 100-108; CORNEA 2000 19 S2-S6
YRSGIIAVV,CLASS-1,HLA-Cw6,,HUMAN,VIRAL,P03191,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1997 185 1605-1617
YSESQLIAKFGT,CLASS-1,H-2d,,MOUSE,BACTERIAL,P13128,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
YSGYIFRDL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P15736,Uniprot,JOURNAL OF GENERAL VIROLOGY 1993 74 2579-2586
YSWMDISCWI,CLASS-1,HLA-A31,,HUMAN,CANCER,not applicable,Uniprot,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
YTAFTIPSI,CLASS-1,HLA-A2,A*0201,HUMAN,VIRAL,P20892,Uniprot,JOURNAL OF VIROLOGY 2001 75 1301-1311
YTEHAKRKTVTAMDVVYA,CLASS-1,H-2b,H-2Db,MOUSE,SELF PEPTIDE,P02304,Uniprot,JOURNAL OF IMMUNOLOGY 2000 165 654-662
YTGDFDSVI,CLASS-1,,Patr-B*01,CHIMPANZEE,VIRAL,P26664,Uniprot,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 1761-1775
YTGDFGSVI,CLASS-1,Patr-B*0101,,CHIMPANZEE,VIRAL,P26663,Uniprot,IMMUNITY 2001 15 883-895
YTKYVFAKAGIS,CLASS-1,H-2d,,MOUSE,BACTERIAL,P21171,Uniprot,JOURNAL OF IMMUNOLOGY 2001 166 1877-1884
YTVFAPTNAA,CLASS-1,H-2b,,MOUSE,BACTERIAL,Q10790,Uniprot,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 151-161
YTVKYPNL,CLASS-1,H-2b,H-2Kb,MOUSE,VIRAL,P09992,Uniprot,NATURE IMMUNOLOGY 2000 1 145-150
YVDDVVLGA,CLASS-1,HLA-A2,,HUMAN,VIRAL,P12933,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2004 285 71-87
YVGDLCGCV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P27954,Uniprot,JOURNAL OF HEPATOLOGY 1999 31 407-415
YVITTQHWL,CLASS-1,HLA-A2,A*0201,HUMAN,CANCER,P40126,Uniprot,CANCER RESEARCH 1998 58 4895-4901
YVLDHLIVV,CLASS-1,HLA-A2,,HUMAN,VIRAL,P03209,Uniprot,EURO.JOURNAL OF IMMUNOLOGY 2000 30 2531-2539
YYHAGTSRL,CLASS-1,H2-d,H2-Kd,HUMAN,VIRAL,P03101,Uniprot,JOURNAL OF IMMUNOLOGICAL METHODS 2001 254 59-66
YYTSAFVFPTKD,CLASS-1,HLA-A33,,HUMAN,n/a,not applicable,Uniprot,JOURNAL OF VIROLOGY 1996 70 7569-7579
